INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

ISTH 2019 Congress

 

July 6-10, 2019 Melbourne
Close
N. Poster
Poster title
Applicant name
Status
  PB-002 Effect of switching from well-controlled vitamin K antagonists to a direct oral anticoagulant for atrial fibrillation on quality of life: little to GAInN Jasper H.A. van Miert Received Received
  PB-003 Real-life anticoagulant treatment with edoxaban in patients with atrial fibrillation and venous thromboembolism: subanalysis of patient with creatinine clearance greater than 95 ml/min. Experience of 26 months in our centre Pablo Romero Garcia Received Received
  PB-004 Comparison of peak and trough concentrations of dabigatran, rivaroxaban and apixaban with the published expected values in patients with non valvular atrial fibrillation Sandra Margetic Received Received
  PB-005 The impact of an educational intervention in patients with atrial fibrillation treated with warfarin: protocol of a clinical trial Luci Dusse Received Received
  PB-006 Oral Anticoagulant Therapy in Patients with Atrial Fibrillation and Flutter in Macedonia Rada Grubovic Rastvorceva Received Received
  PB-009 Efficacy of immunomodulatory therapy for atherosclerosis-role of tolerance and protective antibodies Xinjie Lu Received Received
  PB-011 Immunization with recombinant atherogenic antigen (AHC) does not promote melanoma cell-induced lung cancer In B6;129s-Ldlrtm1herApobtm2sgy/J mice Xinjie Lu Received Received
  PB-012 THE PREVALENCE AND GENETIC BASIS OF SITOSTEROLEMIA IN A GROUP OF TURKISH PATIENTS Zuhre Kaya Received Received
  PB-014 Biochemical and Hemostatic Predictors of Asymptomatic Carotid Atherosclerosis Kostiantyn Stepanchenko Received Received
  PB-018 Large-scale screening for membrane protein interactions involved in platelet-monocyte interactions Yi Sun Received Received
  PB-030 Current Status of Lipid-lowering Therapy and Low-density Lipoprotein Cholesterol Goal Achievement in Hospitalized Acute Coronary Syndrome Patients in Fuzhou, China: A Retrospective Real World Study Hongxin Zhao Received Received
  PB-032 Free Ubiquitin Attenuates Myocardial Ischemia-reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis and Inflammatory Response Jialu Yao Received Received
  PB-034 Current Status of Korea Acute Myocardial Infarction Registry Myung Ho Jeong Received Received
  PB-035 Role of Phospholipase D in processes of myocardial healing after myocardial ischemia and reperfusion injury in mice Meike Klier Received Received
  PB-036 High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: comparison with cryptogenic stroke Anetta Undas Received Received
  PB-040 Microparticles: An Initiator of Thrombosis: The 18500 Feet Martse Mik la Experiment Prosenjit Ganguli Received Received
  PB-042 NEW GENERATION FLOW-CYTOMETRY TO MEASURE CIRCULATING MICROVESISCLES IN CANCER Elena Campello Received Received
  PB-043 Major histocompatibility complex class I related chain A/B positive microparticles associate with severity of acute coronary syndrome Songpol Haohan Received Received
  PB-044 Endothelial- and monocyte-derived microparticles associate with the presence of acute coronary syndrome Nantarat Komanasin Received Received
  PB-045 Phospholipid-dependent procoagulant activity and risk of venous thrombosis in patients with lower-leg injury or knee arthroscopy Carolina Eveline Touw Received Received
  PB-046 Platelet microparticles containing microRNA as a marker of the antiplatelet therapy´s effectiveness Olga Sirotkina Received Received
  PB-049 The Therapeutic Potential of Heparin-binding Copolymer as an Inhibitor of Heparan Sulfate Andrzej Mogielnicki Received Received
  PB-051 Ir-CPI, a FXIa/FXIIa Inhibitor, Provides an Effective and Safe Thromboprotection During Extracorporeal Circulation Associated with Open-heart Surgery Valérie Pireaux Received Received
  PB-052 Evaluation of Hemostasia in the Search of New Anticoagulants of Natural Products: Mikania Laevigata Luci Dusse Received Received
  PB-053 Antithrombotic Effect of the Chimeric (Recombinant Form) of Bauhinia bauhinioides Kallikrein Inhibitor and its Structurally Related Peptide in the Experimental Arterial Thrombosis Model in Mice Maria Luiza Vilela Oliva Received Received
  PB-054 FVII: a human pluripotent stem cell derived hepatocyte model with potential therapeutic applications Maria Eugenia Chollet Dugarte Received Received
  PB-056 A way to make rodent FXIa accessible to human FXIa small molecule inhibitors Mayken Visser Received Received
  PB-057 Thrombin Generation in Trauma Patient Plasma Saulius Butenas Received Received
  PB-061 Supraphysiological intrahepatic bile acid concentrations induce tissue factor activity in hepatocytes Axel Schlagenhauf Received Received
  PB-064 Apixaban suppresses the release of TF-positive microvesicles and restrains cancer cell proliferation through directly inhibiting TF-fVIIa activity Sophie Featherby Received Received
  PB-065 Excess tissue factor is preferentially cleared from endothelial cells through microvesicle release and then, by caveolae-mediated internalisation, through a mechanism requiring fVIIa Yahya Madkhali Received Received
  PB-066 The ratio of factor VIIa:tissue factor content within microvesicles determines the differential influence on endothelial cells Yahya Madkhali Received Received
  PB-067 The cellular location of tissue factor is constrained by MAGI-1 and is releasd by PAR2 activation Mohammad Mohammad Received Received
  PB-068 Long term exposure to tissue factor induce cell proliferation by lowering PTEN protein levels Mohammad Mohammad Received Received
  PB-069 Ex-vivo Trial of BT200 in Healthy Volunteers after Receiving Desmopressin or Endotoxin Katarina D. Kovacevic Received Received
  PB-070 Evaluation of Platelet-dependent VWF Activity on an Heterogeneous Group of von Willebrand Disease Patients Using Four Different Methods: Two VWF:GPIbM and Two VWF:RCo Assays Luciano Baronciani Received Received
  PB-072 Identification of murine Macrophage Galactose Lectin 2 as a novel VWF clearance receptor sheds light on differential clearance pathways for hyposialylated VWF variants Soracha Ward Received Received
  PB-073 VWF production and secretion, and endothelial cell characteristics in healthy ECFCs; Generating a valid ex vivo model for VWD Suzan de Boer Received Received
  PB-076 Digestion of ADAMTS13 by plasmin in human plasma increase the risk of thrombotic thrombocytopenic purpura Yongchol Shin Received Received
  PB-077 Cleavage of von Willebrand factor multimers and fibrinogen in human plasma by Plasmin: Effects on hemostasis response Kenshi Togashi Received Received
  PB-082 Clinical Audit of Prescriptions for Platelet Therapy Using Computerized Physician Order Entry (CPOE Bushra Moiz Received Received
  PB-085 Circulating Intranuclear Proteins May Play a Role in Development of Coagulopathy Following Remission Induction Chemotherapy in Individuals with Acute Leukemia Kayo Harada Received Received
  PB-086 Human Platelets Strongly Interact with Glioblastoma (GBM) Cells: Development of a RNAi-transfected Platelet Strategy for Treatment of Relapsing Glioblastoma Loredana Bury Received Received
  PB-087 Global Distribution of CYP2C19 Genetic Polymorphisms Affecting Safety or Efficacy of Cardiovascular Medications Mohitosh Biswas Received Received
  PB-088 DIGEVAR, a novel software for user-friendly analysis of high-throughput sequencing gene variants in Inherited Platelet Disorders Jose Rivera Received Received
  PB-089 Identification of a shared transcriptomic signature between Sickle Cell Disease and Acute Myocardial Infarction patients Bidossessi Wilfried Hounkpe Received Received
  PB-090 A single-cell survey reveals a subpopulation of mesenchymal stem cell enriched with coagulation function Yuchen Gao Received Received
  PB-091 Analysis of antiproliferative effect of ankaferd blood stopper over caco-2 cancer cells via untargeted proteomics approach Ibrahim Celallettin Haznedaroglu Received Received
  PB-094 Transcriptomics analysis of Melanoma Tumors treated with Amblyomin-X, a Kunitz-type FXa inhibitor, searches for pathways and drug targets Flavio Lichtenstein Received Received
  PB-096 Spatial Thrombin Generation in Platelet-rich Plasma: Sensitivity to the Alterations of Blood Coagulation and Platelet Function Anna Balandina Received Received
  PB-097 The Influence of FXII Deficiency on aPTT in Critically Ill Patients: A Common and Underestimated Problem Mirjam Bachler Received Received
  PB-098 Reversal of the Thrombin Generation Inhibitory Effect of Apixaban, Betrixaban, Edoxaban and Rivaroxaban by Andexanet Alpha may be Associated with Increased Thrombogenesis Fakiha Siddiqui Received Received
  PB-099 Evaluation of Lupus Anticoagulant Interference in a Chromogenic Factor IX Kit for Determination of Factor IX Activity Pia Bryngelhed Received Received
  PB-101 Analytical Validation of Atellica COAG 360 System Renata Zadro Received Received
  PB-105 Bringing Thrombin Generation into the Diagnostic Setting: Standardisation and Establishment of Normal Reference Intervals for a Commercial Thrombin Generation System Sarah Just Received Received
  PB-106 Comparison of Paired Placental and Venous Neonatal Blood Samples for Coagulation Assay Erica Scalambrino Received Received
  PB-108 Analytical Performance of the Free Protein S Assay on the Cobas t 711 Analyser Steve Kitchen Received Received
  PB-110 A Novel, Point-of-Care (POC), Hand-held Meter & Strip, Viscoelastic Coagulation Diagnostic Platform for Thromboelastography (TEG) Measurement Abhishek Ramkumar Received Received
  PB-112 Comparative Study between Thromboelastography and Conventional Coagulation Tests in Ischemic Cerebral Vascular Disease Bin Yan Received Received
  PB-115 Comparison of Thrombin Generation Measured with Calibrated Automated Thrombography versus ST Genesia in Patients with Chronic Liver Disease Lara N. Roberts Received Received
  PB-116 Analytical Performance of the Lupus Screen and Lupus Confirm Assays on the Cobas t 711 Analyser Gergely Rozsnyai Received Received
  PB-118 Analytical Performance of the Factor X Assay on the cobas t 711 Analyser Steve Kitchen Received Received
  PB-121 Integration of routine coagulation tests on a total laboratory automation (TLA) platform in an academic laboratory in South Africa Susan Louw Received Received
  PB-122 Evaluation of the performance characteristics of a commercial lyophilized normal pool plasma for utilization in the routine coagulation laboratory Susan Louw Received Received
  PB-125 Effect of dabigatran in the very elderly on thrombinography and fibrinography parameters as assessed with the Thrombodynamics® system Geoffrey Foulon Received Received
  PB-126 A method to quantify alpha- and beta-antithrombin in plasma Helen Atkinson Received Received
  PB-127 Analytical measuring range of exogenous coagulation factors assays with a new extraction thromboplastin Audrey Carlo Received Received
  PB-128 Comparison of two thromboplastin reagents for exogenous coagulation factor quantitative determination Audrey Carlo Received Received
  PB-129 Reference Range of Platelet Function Analyzer-100 Closure Time (CT) in Thai Adolescent Narin Khongjaroensakun Received Received
  PB-130 Exclusion of heparin-induced thrombocytopenia by a rapid lateral-flow immunoassay. Comparison to an immunoturbidimetric assay: Preliminary results Marina Lopez Received Received
  PB-131 Evaluation of coagulation profile in patients with adrenal incidentaloma: a two-center observational study Elena Campello Received Received
  PB-132 Establishment of a Healthy Donor Reference Range for the T-TAS 01 PL Chip Jeffrey Dahlen Received Received
  PB-133 Analytical Performance Characteristics of the T-TAS 01 PL Chip Assay Jeffrey Dahlen Received Received
  PB-134 Estimation of the influence of HBB mutation site for the screening ability of calculated RBC indices in ß-thalassemia minor Soyoung Shin Received Received
  PB-136 Identifying reasons of excessive coagulation testing in medically ill patients - a sneak peek Sidra Asad Ali Received Received
  PB-137 Thromboelastography parameters in normal pregnancies Elvira Grandone Received Received
  PB-138 Converting the Distinct Heparins Sourced from Bovine or Porcine Mucosa into a Single Anticoagulant Drug Stephan-Nicollas M. C. G. de Oliveira Received Received
  PB-139 Ongoing improvements in laboratory performance of coagulation factors VIII and IX: Recent experience from the RCPAQAP Emmanuel Favaloro Received Received
  PB-140 Are Global Coagulation Assays Better Measures of the Intensity of Anticoagulation in Patients with Antiphospholipid Syndrome? Wan Hui Wong Received Received
  PB-142 Pronounced alterations of thrombin generation profiles are found in whole blood compared to plasma of liver disease patients Jun Wan Received Received
  PB-147 Effects of hemolysis on prothrombin time (PT) and activated partial thromboplastin time (APTT) clot waveform analysis (CWA) Yu Ling Clarice Lee Received Received
  PB-148 Antithrombin - prothrombin balance in cirrhosis-associated hypercoagulability Aurelien Lebreton Received Received
  PB-149 Evaluation of a new high-throughput haemostasis analyser using coagulation, amidolytic, immuno-turbidometric and light transmission aggregometry assays Ian Mackie Received Received
  PB-151 The new QXpert analyser is suitable for routine use in high volume haemostasis laboratories Anita Woolley Received Received
  PB-156 A practical method for reducing the interference due to lipaemia in coagulation tests Ian Mackie Received Received
  PB-157 External Quality Assessment Scheme for Haemostasis Laboratories in India - Challenges and Opportunities Alok Srivastava Received Received
  PB-158 Thrombin generation measurement using the automated ST Genesia Thrombin Generation System in Healthy Adults and Some Adult Patients Sara Calzavarini Received Received
  PB-161 Responsiveness of the Activated Partial Thromboplastin Time (APTT) and Dilute Thrombin Time (dTT) to Argatroban: Resuls of a in vitro Study Erica Scalambrino Received Received
  PB-162 Mechanisms of Paradoxical Prolongation of Clot Lysis Time by a Direct Thrombin Inhibitor Melagatran: Comparison with a Direct Factor Xa Inhibitor Edoxaban Yoshiyuki Morishima Received Received
  PB-163 Heterogeneous Effect of Direct Oral Anticoagulants on Lupus Anticoagulant Assays Tomas L. Lindahl Received Received
  PB-165 High Variability in Rivaroxaban and Apixaban Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessed with Thrombin Generation in Patients over 80 Years Geoffrey Foulon Received Received
  PB-166 A Novel, Point-of-Care (POC), Hand-held Meter & Strip, Viscoelastic Coagulation Diagnostic Platform for Anticoagulation Therapy Monitoring Abhishek Ramkumar Received Received
  PB-167 Neutralising Rivaroxaban Induced Interference in Laboratory Testing for Lupus Anticoagulant (LA): A Comparative Study Using DOAC Stop and Andexanet Alfa Emmanuel Favaloro Received Received
  PB-169 Coagulation Function Tests to Measure Direct Oral Anticoagulant (DOAC) Levels: Comparison of Routine and DOAC-specific Tests in the PAUSE Study James Douketis Received Received
  PB-172 Correlation of TEG6S with Rivaroxaban level: An Advancement in Point-of-Care Testing Matthew Neal Received Received
  PB-174 Evaluation of anti-factor Xa assays for monitoring indirect Xa inhibitors using external quality data Piet Meijer Received Received
  PB-176 Evaluation of single-site and multisite precision of apixaban assay Audrey Carlo Received Received
  PB-178 DOAC filter efficacy and interest in patients undergoing LA testing Audrey Carlo Received Received
  PB-180 Characterization by 5 Different Methods of 16 Structural Variants in SERPINC1 Causing Antithrombin Deficiency Javier Corral Received Received
  PB-181 Activated Charcoal Is an Effective in vitro Removal Agent of Dabigatran and Rivaroxaban in Plasma of Patients Who Need Lupus Anticoagulant Testing Ivana Celap Received Received
  PB-182 Activated Charcoal for Lupus Anticoagulant Diagnosis in Patients Treated with Direct Oral AntiCoagulants: Results of a Multicenter Study Virginie Siguret Received Received
  PB-184 Use of a Novel Assay to Measure Anti-factor Xa Direct Oral Anticoagulant Levels in the Plasma Samples from the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study Luca Di Giuseppantonio Received Received
  PB-186 Assessment of an Adsorbent Product to Neutralise the Effect of DOACs on Coagulation Testing Joanne Clifford Received Received
  PB-188 Mixing Study to Establish the Diagnosis of Type II Antithrombin Deficiency: A Case Report Mihir Bhatt Received Received
  PB-189 Improved Correlation between DOAC Concentrations and Clotting Test Results using the Correction Ratio (before/after DOAC Stop) Thomas Exner Received Received
  PB-190 Lack of agreement between different anti-Xa assays to measure low molecular weight heparin (LMWH); results of a UK NEQAS Blood Coagulation study Ian Jennings Received Received
  PB-192 Chronometric vs structural hypercoagulability Carmen Delianu Received Received
  PB-193 A factor Xa inhibitor antidote (andexanet alfa) is capable of neutralizing the anticoagulant effects of unfractionated heparin of bovine, ovine and porcine origin in a comparable manner as protamine sulfate Fakiha Siddiqui Received Received
  PB-194 The (Fab)ulous destiny of idarucizumab: highlighting the interference with urine protein immunofixation Nicolas Gendron Received Received
  PB-195 Measurement of Anti-FIIa activity of Bivalirudin in Plasma with Clotting and Chromogenic Assays Claire Dunois Received Received
  PB-196 Neutralization of Heparin Interferences in DOACs´ Measurement with Anti-Xa Chromogenic Assays Claire Dunois Received Received
  PB-197 Bio-assay for the Measurement of Anti-FXa Activity of Edoxaban and its Metabolites in Plasma Claire Dunois Received Received
  PB-198 Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Does Not Fully Reflect their Biologic Spectrum Fakiha Siddiqui Received Received
  PB-200 Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can Be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma Fakiha Siddiqui Received Received
  PB-202 Study of the Serum Immunoglobulin and Cell-mediated Immunity in Patients with Congenital Severe Hemophilia Mehran Karimi Received Received
  PB-203 Biochemical Evidence and Functional Effects of Molecular Aggregation of Marketed Recombinant FVIII Products Raimondo De Cristofaro Received Received
  PB-204 Quality Control in Hemophilia: Perfomance Evaluation of Eighteen Laboratories in Argentina Pablo Martinez Received Received
  PB-207 High Prevalence of Recurrent F8 Genotypes in the First Series of Argentine Patients with Mild Hemophilia A Liliana Rossetti Received Received
  PB-211 Factor VIII pharmacokinetics associate with VWF clearance, VWF-FVIII binding activity, and variants in the CLEC4M gene in an adult hemophilia A population Kenichi Ogiwara Received Received
  PB-213 Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations Alessio Branchini Received Received
  PB-214 Evaluation of single-site and multisite precision of factor IX measurement Claire Martin Received Received
  PB-215 Evaluation of single-site and multisite precision of factor VIII measurement Claire Martin Received Received
  PB-218 An Inv22-like F8 Inverted Disruption in Severe Hemophilia A Brothers Possibly Occurring from Template Switching between Sister Chromatids Shogo Tamura Received Received
  PB-219 Dosage of factor IX in persons with Hemophilia B treated with recombinant FIX linked to an IgG Fc domain: comparison of 3 methods in a French hospital Valérie Proulle Received Received
  PB-222 Bone Disease in Hemophilia: The Role of Different Bone Cells Stefano Lancellotti Received Received
  PB-223 Co-administration of FVIII with IVIG: Effect on Immune Response to FVIII in Hemophilia A Mice Gonzalo Hortelano Received Received
  PB-224 Synergistic effect of the bypassing agents and sequence identical analogue of emicizumab on secondary hemostasis in in vitro model of hemophilia A Jovan Antovic Received Received
  PB-225 Severe haemophilia A caused by an unbalanced chromosomal rearrangement identified using nanopore sequencing Claude Négrier Received Received
  PB-226 Rotem analysis shows variable clot formation in subjects with intron 22 inversion- a possible explanation for the variable phenotype Colleen Hamid Received Received
  PB-227 Low plasma level of OPG in hemophilia A boys Zhenping Chen Received Received
  PB-230 Improvement the APTT-based Mixing Test for Anti Factor VIII Emanuel Sueldo Received Received
  PB-231 Validation of an Automate Chromogenic Assay Factor VIII:C Emanuel Sueldo Received Received
  PB-232 Thrombin Generation in Subjects with Hemophilia A According to the ABO Blood Group Fernanda Martins Lott Fonseca Received Received
  PB-234 Improved Hemostasis and Joint Health over Time in a Subset of Patients who Did Not Reach Optimal Hemostatic Control in the First Year of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Therapy K. John Pasi Received Received
  PB-236 Immune Tolerance Induction Using Low-dose Fc Fusion Recombinant Factor VIII on Emicizumab in Hemophilia A Patients with Inhibitors, Tokyo Protocol Azusa Nagao Received Received
  PB-237 Comparison of Pharmacokinetic Parameters of Two Different Extended Half-life factor VIII Concentrates in Hemophilia A (HA) Patients Jerome Teitel Received Received
  PB-238 Successful Haemostatic Response during the Treatment of Bleeding Episodes and Effective Prophylaxis with Turoctocog Alfa in Previously Treated Patients from China with Severe Haemophilia A (Guardian 7) Renchi Yang Received Received
  PB-239 N8-GP Treatment Sustains Low Bleeding Rates in Patients with Haemophilia A Meera Chitlur Received Received
  PB-240 Quality of Life of Hemophilia Patients with Inhibitors - Opportunities for Improvement Howard Levy Received Received
  PB-241 Daratumumab in Combination with Rituximab and Immune Tolerance Induction Can Rapidly Eradicate High-titer Factor VIII Inhibitor in a Patient with Hemophilia A Chatphatai Moonla Received Received
  PB-242 Long-term Safety and Efficacy of Nonacog Beta Pegol in Previously Treated Children with Haemophilia B, Treated for at Least 5 Years Manuel Carcao Received Received
  PB-247 Public Health Policy Analysis of Clotting Factor Concentrate Procurement Policy in Canada Zachary Liederman Received Received
  PB-248 D-dimer Levels in Haemophilic Patients Brigitte Tardy-Poncet Received Received
  PB-249 Relationship between Serum Cartilage Turnover Biomarkers and Hemophilic Arthropathy Severity in Adult Patients with Severe Hemophilia A in China Xueyan Sun Received Received
  PB-251 Perioperative Management of Eight Patients with Congenital Hemophilia A who Underwent Spinal Surgery in a Single Facility Yushi Chikasawa Received Received
  PB-254 The WFH World Bleeding Disorders Registry - One Year Later Barbara Konkle Received Received
  PB-255 Pharmacokinetic analysis in Hemophilia patients using WAPPS-Hemo: the experience of a single center Alessandra Nunes Loureiro Prezotti Received Received
  PB-256 Hereditary Protein S Deficiency in a Family with Hemophilia B- Case Report Alessandra Nunes Prezotti Received Received
  PB-259 The gene mutation and factor activity of hemophilia carriers in China Qun Hu Received Received
  PB-260 Expected timing of initial exposure to factor VIII treatment in non-replacement therapies in hemophilia A Fabienne Roelfien Kloosterman Received Received
  PB-261 Cross-sectional comparative study of pharmacokinetics and efficacy after the switch between Kogenate and Kovaltry guided by WAPPS-Hemo Santiago Bonanad Received Received
  PB-264 Web-based Application for the Population Pharmacokinetic Service (WAPPS)´s Impact on Dosage Selection: A Single Pediatric Centre Experience, Retrospective Review Celia Kwan Received Received
  PB-265 Unexpected diagnostic of aggressive stage IV non Hodgkin Lymphoma in a severe hemophilia A patient Melen Brinza Received Received
  PB-267 Effects of Preventive Physiotherapy on Joint Function and Health-related Quality of Life in Pediatric Patients with Severe Bleeding Disorders Ralf Knoefler Received Received
  PB-268 Extended half-life recombinant factor IXFc is effective in preventing bleeding after major and minor surgery in severe Factor IX deficiency Kate Johnston Received Received
  PB-270 Circumcision and Complications in Patients with Hemophilia and the Other Bleeding Disorders in Southern Part of Turkey: Cukurova Experience Ali Bulent Antmen Received Received
  PB-271 Intracranial Hemorrhage and Management in Hereditary Bleeding Disorders: The Experience of Cukurova Hatice Ilgen Sasmaz Received Received
  PB-272 OLD HEMOPHILIA PATIENTS HAVE PROBLEMS OTHER THAN BLEEDING: LIKE CANCER Fahri Sahin Received Received
  PB-287 Performance of a Clinical Risk Prediction Model for Inhibitor Formation in Severe Hemophilia A Shermarke Hassan Received Received
  PB-290 Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Simoctocog Alfa and 2 Plasma-derived Factor VIII Concentrates: A Snapshot Analysis of a Prospective, Non-interventional Study to Evaluate Real-life Prophylactic Treatment Schedules - N Carmen Escuriola-Ettingshausen Received Received
  PB-291 New Inhibitors in the Ageing Hemophilia Population (NIAP) Study: An International, Retrospective, Observational, Cohort Study of New Inhibitors in People with Hemophilia Aged 40 Years and Older Jan Astermark Received Received
  PB-292 Prophylaxis with Emicizumab in Children and Adults with Hemophilia A and Inhibitors: Preliminary Data on 7 Patients of a Portuguese Hemophilia Center Cristina Catarino Received Received
  PB-293 Circumcision in Haemophilia in the Setting of Low Factor Availabilty: Experience from Gombe, Nigeria Saleh Yuguda Received Received
  PB-306 Systemically administered LV-FVIII and LV-FIX confers normal level of clotting factor expression with no evidence of oncogenesis in non-human primates Rob Peters Received Received
  PB-307 FVIII Expression by its Native Promoter Sustains Long-term Correction Avoiding Immune Response in Hemophilic Mice Antonia Follenzi Received Received
  PB-310 Correction of Canine Hemophilia A via Intraosseous Delivery of a Platelet-specific Factor VIII-lentiviral Vector Chong Li Received Received
  PB-316 Development of Single Domain Antibodies Targeting Protease Nexin-1 as a Strategy for Hemophilia Treatment Charlotte Kawecki Received Received
  PB-317 A Comparison of Clot Waveform Analysis and Thrombin Generation Assay in the Laboratory Assessment of Haemostatic Function in a Patient on Emicizumab Joyce Ching Mei Lam Received Received
  PB-318 Treatment of Hemophilia A Using Factor VIII Messenger RNA Encapsulated in Lipid Nanoparticle Chun-Yu Chen Received Received
  PB-319 Management of surgery in hemophilia A patients with inhibitors during emicizumab prophylaxis Christine Biron-Andreani Received Received
  PB-320 Next Generation Factor VIIa with Enhanced Half-Life Mattia Ferrarese Received Received
  PB-321 Rescue of multiple Haemophilia A-causing mutations by a single ExSpeU1: the importance of the genomic context Dario Balestra Received Received
  PB-326 The Role of Platelet Mitochondrial Function for Platelet Mediated Aß40 Aggregation Lili Donner Received Received
  PB-328 Platelet-derived calpain mediates protease-activated receptor 1-dependent vascular inflammation in Diabetes Voahanginirina Randriamboavonjy Received Received
  PB-331 Disturbed Blood Flow-induced Platelet Transmigration Modulates Vascular Inflammation Chaojun Tang Received Received
  PB-335 Statins Effects on Endothelium Dependent Relaxation of Rat Resistance Arteries Affected by Homocysteine Exposure Loredana Liliana Hurjui Received Received
  PB-336 Development of an Algorithm to Predict Mortality in Patients with Sepsis and Coagulopathy Matthew Rondina Received Received
  PB-337 The Anti-inflammatory effect of e-viniferin by Specifically Targeting fMLP Receptor in Human Neutrophils Hsiang-Ruei Liao Received Received
  PB-339 Aspirin Inhibits Intravascular Coagulation during Sepsis in Mice Agostina Carestia Received Received
  PB-341 Standardisation of Protocols for the Diagnosis of Neonatal Sepsis by Molecular Methods Anjali Kelkar Received Received
  PB-342 PECAM-1 protects sepsis-induced DIC by dampening inflammatory response and restoring vascular barrier Heng Mei Received Received
  PB-345 Role of the thrombotic markers, NETs and thrombin generation test, in the diagnosis of prosthetic infection Julia Oto Received Received
  PB-347 Plasma Thrombogenic Potential in Patients with Granulomatosis with Polyngiitis (GPA) Jacek Musial Received Received
  PB-348 CENTD-centre of Excellence in New Target Discovery: The Use of Animal Venoms to Identify Molecular Targets and Signaling Pathways Involved in Inflammatory Related Diseases Ana Marisa Chudzinski-Tavassi Received Received
  PB-349 Neutrophil-to-Lymphocyte ratio is associated with poor prognosis after endovascular thrombectomy in stroke patients Manuel Navarro-Oviedo Received Received
  PB-351 Natural IgM antibodies reduce plasmatic coagulation Christoph J Binder Received Received
  PB-352 Plasma levels of microRNAs and future risk of incident venous thromboembolism Vânia Maris Morelli Received Received
  PB-354 Coxsackievirus B3 decreased angiogenic activity of endothelial colony forming cells through TLR3 activation Paula Romina Zubiry Received Received
  PB-355 Association of Platelet Response to Cilostazol with Clinical Outcome and CYP Genotype in Patients with Cerebral Infarction Yuichi Ikeda Received Received
  PB-356 Investigation of the in vitro Effect of Aspirin and Tirofiban in Children Compared to adults Xavier Busuttil-Crellin Received Received
  PB-357 Value of High Platelet Reactivity in Predicting Major Adverse Cardiovascular Events in Hypertension Patients with Coronary Atherosclerotic Heart Disease after PCI Qinkun Fan Received Received
  PB-358 Effect of cilostazol in combination with clopidogrel on platelet function in patients with ischemic stroke at high risk of recurrence Masako Yamazaki Received Received
  PB-359 Evaluation of the Newly-developed ADP induced platelet aggregation level (APAL) system in aggregometer on automated coagulation analyzer Tasuku Sakayori Received Received
  PB-360 ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA Marco Cattaneo Received Received
  PB-361 Clinical predictiveness of six major platelet function tests used to assess aspirin response in patients with stable coronary artery disease - 10-year follow-up Marie Lordkipanidzé Received Received
  PB-362 Management of antiplatelet therapy in the pacemaker implant. Retrospective study in our intensive care unit Pablo Romero Garcia Received Received
  PB-363 Efficacy and Adverse Reactions of Hydroxyurea and Interferon-alpha in a Cohort of Chinese Patients with Essential Thrombocythemia Xinyue Dai Received Received
  PB-364 Development of Novel Drug-Eluting Stents for Acute Myocardial Infarction to Prevent Stent Thrombosis Myung Ho Jeong Received Received
  PB-365 Reversing oral antiplatelet agents with platelet transfusion: a review Paul Kruger Received Received
  PB-366 Reversal of the anti-aggregant effect of ticagrelor using untreated platelets Paul Kruger Received Received
  PB-368 Aspirin and Clopidogrel Resistance in Patients with Ischemic Vascular Disease in Indonesian Hospital Vivien Puspitasari Received Received
  PB-369 Prospective Evaluation of the HEP Score and 4Ts Score in Patients with Suspected Heparin-induced Thrombocytopenia from China Sen Li Received Received
  PB-370 Performance Characteristics of Latex Immunoturbidimetric Assay and Particle Immunofiltration Assay for the Diagnosis of Immune Heparin-induced Thrombocytopenia Shu-Jie Wang Received Received
  PB-373 Serological Investigation of Suspected Heparin Induced Thrombocytopenia in China: 69 Hospitals Qingkun Fan Received Received
  PB-375 Clinical Outcomes in Patients with Discordant Heparin-Induced Thrombocytopenia Laboratory Testing Zi Yun Ng Received Received
  PB-377 Transition from argatroban to vitamin K antagonists in the real life : chromogenic factor X assay alone fails to predict international normalized ratio Dorothée Faille Received Received
  PB-378 Fondaparinux in patients with heparin-induced thrombocytopenia and dialysis; a case report, and systematic review of available literature Matthew Wanat Received Received
  PB-379 Fibrin monomers to monitor anticoagulation with argatroban in patients with acute heparin induced thrombocytopenia Dorothée Faille Received Received
  PB-380 Implementation of electronic 4T score improves platelet factor 4 (PF4) ELISA utilization Lisa Baumann Kreuziger Received Received
  PB-381 Autoimmune HlT - Successful Treatment with IvigG and DOAC and Laboratory Testing of ivIgG Therapy in HIPA-test Karina Althaus Received Received
  PB-382 Natural History of Heparin-induced Thrombocytopenia (HIT) in Cancer: A Cohort Analysis of Thrombosis and Bleeding Outcomes Cristhiam Mauricio Rojas Hernandez Received Received
  PB-383 Abnormal Expression of CD47 on Platelet Surface Participates in the Pathogenesis of ITP Zeping Zhou Received Received
  PB-384 Abnormal Expression of APRIL may be Involved in the Pathogenesis of ITP Zeping Zhou Received Received
  PB-385 Glycoprotein-Specific Direct Platelet Autoantibody Testing in Immune Thrombocytopenia: A Modern Reassessment David Kuter Received Received
  PB-386 Immature Platelet Fraction as a Predicting Factor for Hemorrhage in Immune Thrombocytopenic Purpura Huu Tuan Nguyen Received Received
  PB-387 High Dose Dexamethasone vs Prednisolone Therapy in Newly Diagnosed Myanmar Adult Patients with Primary Immune Thrombocytopenia HtunLwin Nyein Received Received
  PB-389 Detection and Treatment of Helicobacter pylori in Patients with Immune Thrombocytopenia: An International Survey Prakash Vishnu Received Received
  PB-390 The let-7b-5p Contributes to B Cell Activation and Survival in the Pathogenesis of Immune Thrombocytopenia by Targeting ADAM10 Yang He Received Received
  PB-391 "Wait and Watch Approach" for ITP in Kabuki Syndrome Mona Faramawy Received Received
  PB-393 Levels of Cytokines Secreted by T lymphocyte and the Relationship with Prognosis in Children Immune Thrombocytopenia Jingyao Ma Received Received
  PB-394 Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children: a single-center observational study Hao Gu Received Received
  PB-395 Fibrinogen levels are associated with bleeding in patients with Immune thrombocytopenia Heng Mei Received Received
  PB-397 Evaluation of therapeutic response in pediatric immune thrombocytopenic purpura (ITP) patients Kousar Perveen Received Received
  PB-399 Baseline Endogenous Thrombopoietin Concentrations and Response to Avatrombopag in Immune Thrombocytopenia David Kuter Received Received
  PB-401 A systematic review and meta-analysis of the use of thrombopoietin receptor agonists in patients with primary Immune Thrombocytopenia Marco Cattaneo Received Received
  PB-402 Response to treatment of paraneoplastic immune thrombocytopenia (ITP): a systematic review Marco Cattaneo Received Received
  PB-403 Mutation Spectrum of ITP by NGS Sequencing Mankai Ju Received Received
  PB-404 The effect of laparoscopic splenectomy for chronic ITP patients Jun He Received Received
  PB-405 Clinical Profile and Treatment Outcome of ITP In Malaysia: A Single Centre Experience Tze Shin Leong Received Received
  PB-408 Clinical patterns and response to treatment of a cohort of immune thrombocytopenia patients in Singapore Shin Yeu Ong Received Received
  PB-409 Immune thrombocytopenic purpura management and outcome: A single center study Munira Borhany Received Received
  PB-411 Increased platelet size and pre-activation are associated with bleeding in children with chronic but not persistent immune thrombocytopenia Anastasia A. Ignatova Received Received
  PB-413 The Efficacy and Safety of Short Course High-dose Dexamethasone as First-line Treatment regimen for Childhood Newly diagnosed Immune Thrombocytopenia Lingling Fu Received Received
  PB-414 A 5 year retrospective longitudinal study of assessment and initial treatment of acute ITP in adults John Hanley Received Received
  PB-415 The Role of Flow Cytometric Detection of Platelet Associated Immunoglobulins in Immune Thrombocytopenic Purpura Diagnosis Andra Grigore Received Received
  PB-416 Comparable Avatrombopag (AVA) Efficacy in Patients with Chronic Immune Thrombocytopenia (c-ITP) Following Failure of Prior Thrombopoietin Receptor Agonist (TPO-RA) Treatment Michael Vredenburg Received Received
  PB-417 Avatrombopag (AVA) Dosing Regimen in Chronic Immune Thrombocytopenia (ITP) - A Dose Modeling Study Michael Vredenburg Received Received
  PB-418 Lack of Clinically Significant Hepatotoxicity in Patients with Chronic Immune Thrombocytopenia (c-ITP) Treated with the Novel, Oral Thrombopoietin Receptor Agonist Avatrombopag-pooled Safety Analysis of Four Clinical Trials Michael Vredenburg Received Received
  PB-421 In vitro Blockage of CD72 Dose Not Influence ITP Patients Lymphocyte Proliferation and Platelet Antibody Secretion Jianhui Xu Received Received
  PB-422 Measuring Preplatelet Division: An Imaging Cytometry Approach Paul Harrison Received Received
  PB-424 Imaging actin dynamics throughout megakaryocyte ingression membrane system development Steve Thomas Received Received
  PB-427 Differential Effects of Ticagrelor with or without Aspirin on Platelet Reactivity and Coagulation Activation Ludwig Traby Received Received
  PB-429 Disagregin: a possible new aIIbß3 integrin inhibitor to prevent arterial thrombosis Tilman M. Hackeng Received Received
  PB-430 Amplified Antithrombotic Effects of a Novel GPVI Inhibitor ACT017 when Used in Combination with Aspirin and Ticagrelor Fawaz Alenazy Received Received
  PB-431 APAC, a dual anticoagulant and antiplatelet, synergistically with acetylsalicylic acid inhibits collagen-induced platelet aggregation Riitta Lassila Received Received
  PB-435 The Active Recruitment of Red Blood Cells during Hemostasis and Thrombus Formation Meike Klier Received Received
  PB-440 Critical Role of Platelet-Derived VWF in Acute Occlusion of Stenosed Arteries Katrina J Ashworth Received Received
  PB-442 The Effect of Fibrinogen in Platelet Function Activity Using Viscoelastic Method among Neurological Disorder Patient Leni Lismayanti Received Received
  PB-444 Flow Cytometry Mepacrine Uptake/Release Combined with CD63 Assay in Diagnosis of Patients with Platelet Disorders Mara Agazzoni Received Received
  PB-445 A Method for Determining the Density and Architecture of in vitro Thrombi Formed under Flow Joanne Mitchell Received Received
  PB-448 Platelet Ageing Causes Changes in Key Metabolic and Structural Proteins Harriet E. Allan Received Received
  PB-449 HLA I cell surface expression is a reliable marker to identify young platelets Arnaud Dupuis Received Received
  PB-451 The Effect of Thrombin Binding to GPIba on its Binding with von Willebrand Factor Shinya Goto Received Received
  PB-455 Cold-stored Platelets: Procoagulant or Apoptotic? Lacey Johnson Received Received
  PB-456 Calcium ion chelation preserves platelet function during cold storage Guoying Zhang Received Received
  PB-457 Characterization of outside-in aIIbß3 signaling in platelets by Protein Kinase Cd Preeti Kumari Chaudhary Received Received
  PB-461 The cell-cycle control pathway Gwl/MASTL-ENSA/ARPP19-PP2A is present and active in human platelets Elena Kumm Received Received
  PB-465 Acute Phase Neutrophil Trafficking is Orchestrated by Platelet Serotonin Maximilian Mauler Received Received
  PB-467 Extracellular Vesicles secreted by activated CD4+ T cells activate platelets Maria Albertina Romaniuk Received Received
  PB-475 Triple Positivity Profile of Antiphospholipid Antibodies (aPL) is Associated with a Greater Amount of Non-criteria Manifestations on Obstetric Antiphospholipid Antibodies Syndrome (OAPS) Gabriela de Larrañaga Received Received
  PB-476 Standardization and Reliability of Lupus Anticoagulant Tests: Comparison of Real World and Core Laboratory Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Analysis Maria Efthymiou Received Received
  PB-477 Immunothrombosis and the Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Antiphospholipid Syndrome Nevine Kassim Received Received
  PB-478 Prevalence and Clinical Significance of Protein C Antibodies and Acquired Activated Protein C Resistance in Systemic Lupus Erythematosus Maria Efthymiou Received Received
  PB-479 Systematic Review and Case Series of Patients with Antiphospholipid Syndrome and Myeloproliferative Neoplasm Zara Sayar Received Received
  PB-480 Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women with Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss Eva Nicole Hamulyák Received Received
  PB-481 High Antiphospholipid Antibody Positivity among Children and Adolescents with Non-Transfusion-Dependent Thalassemia Nongnuch Sirachainan Received Received
  PB-483 Citrullinated Histone H3, a Marker of Neutrophil Extracellular Trap Formation, is increased in Patients with persistent Lupus Anticoagulant and a History of Thrombosis Lena Hell Received Received
  PB-486 SHE WON´T STOP CLOTTING DESPITE ON ANTICOAGULANTS: A CHALLENGING CASE Bee Sun Lee Received Received
  PB-487 Cut-off generation for percent correction of screen by confirm in lupus anticoagulant testing in multiple reagents with a common set of normal donor plasmas Osamu Kumano Received Received
  PB-488 The usefulness of paired APTTs by low and high lupus anticoagulant sensitivity for the discrimination in direct oral anticoagulant drug samples Osamu Kumano Received Received
  PB-489 Intestinal permeability: an etiological factor in obstetric antiphospholipid syndrome? Valérie Louise Bernice Isabelle Jansen Received Received
  PB-490 Successful Treatment with Eculizumab in a Patient with Antiphospholipid Syndrome Presenting with a Thrombotic Storm Hana Lim Received Received
  PB-493 High Incidence of Antiphospholipid Antibody Positivity in Newly-Diagnosed Lymphoma Patients and A Proposed APLA Predictive Score Theera Ruchutrakool Received Received
  PB-494 Unfavorably altered plasma fibrin clot properties are associated with increased antiphosphatidylserine/prothrombin complex antibodies in patients with antiphospholipid syndrome Anetta Undas Received Received
  PB-495 Thrombin generation in normal plasma spiked with total IgG and affinity purified aß2GPI from high risk APS patients Vittorio Pengo Received Received
  PB-496 PFA-200 short closure time values induced by triple positive APS patients´ total IgG or anti Beta 2 GPI antibodies Vittorio Pengo Received Received
  PB-497 MicroRNAs Identification in Primary Antiphospholipid Syndrome Camila de Oliveira Vaz Received Received
  PB-498 Plasmatic Oxidative Stress in Patients with Primary Antiphospholipid Syndrome : a Preliminary Study Camila de Oliveira Vaz Received Received
  PB-499 Anti-cardiolipin and anti-ß2glycoprotein I IgA along with the current criteria does not have an added value in screening for clinical symptoms of the antiphospholipid syndrome Walid Chayoua Received Received
  PB-500 Gene expression of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome Camila Vaz Received Received
  PB-501 Changes in Inflammation and Coagulation Markers in Patients with Thrombotic Primary Antiphospholipid Syndrome Treated with Hydroxychloroquine Camila Vaz Received Received
  PB-503 Platelet Hemi-ITAM Signaling Mediated Cancer-associated Venous Thrombosis Inhibited by a Mononclonal Antibody to Podoplanin, SZ-168 Yiming Zhao Received Received
  PB-505 Influence of P Selectin Glycoprotein Ligand 1 Polymorphisms on the Development of Thrombosis in Myeloproliferative Neoplasm Patients Rolandas Gerbutavicius Received Received
  PB-509 Increase in whole blood clot Stiffness in patients with peritoneal carcinomatosis Shahsoltan Mirshahi Received Received
  PB-510 The role of DNA and Histone in the rigidity and viscoelasticity of fibrin clots Massoud Mirshahi Received Received
  PB-511 Higher Plasma clot elasticity decreases Clot degradability Massoud Mirshahi Received Received
  PB-512 Approach in the study of molecular mechanism in cancer cell implantation on the fibrin network Massoud Mirshahi Received Received
  PB-515 Proteomic Investigation of In-Vitro Antineoplastic Effect of Ankaferd Hemostat with 2D Gel Electrophoresis and MALDI-TOF/TOF-MS in HepG2, Caco-2 and HT-29 Cancer Cells Ibrahim Celalettin Haznedaroglu Received Received
  PB-518 Cancer-associated Thromboembolism: Antithrombotic Management of Patients Hospitalized at an Academic Medical Center Larry K. Golightly Received Received
  PB-522 Differential Gene Expression of Protease-activated Receptors in Solid Tumors Compared to Hematologic Neoplasias Prakash Vishnu Received Received
  PB-524 A Real World Comparative Effectiveness Analysis of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin among Medically Ill and Abdominal Surgery Patients in a large US Hospital Database Zhimin Xiao Received Received
  PB-525 Effectiveness of an Admission Proforma in Improving Prescription of Thromboprophylaxis in Acutely Ill Medical Patients. Re-valuating Current Performance in University Hospital Limerick (Ireland) a Decade Later Robert Gilligan Received Received
  PB-526 Comprehensive VTE Prevention Strategy Including Root Cause Analysis of Hospital-associated Thrombosis Significantly Reduces Potentially Preventable Events: A Single Centre Experience Lara N. Roberts Received Received
  PB-527 Benefit-Risk Assessment of 10mg Daily Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness Gary E. Raskob Received Received
  PB-528 Extended-Duration Thromboprophylaxis with Rivaroxaban Reduces the Risk of Major and Fatal Vascular Events in Hospitalized Medically Ill Patients Alex C. Spyropoulos Received Received
  PB-530 Incidence of Venous Thromboembolic Disease in hospitalized patients at the "Hospital de Clínicas", Montevideo - Uruguay Cecilia Guillermo Received Received
  PB-531 Adequacy of Hospital Thromboprophylaxis and Risk Assessment Models in the SWITCO65+ Cohort Marc Blondon Received Received
  PB-532 Prophylaxis for Hospital Acquired Venous Thromboembolism: Why VTE Could Not Be Prevented Anoop Enjeti Received Received
  PB-535 Risk Factors Associated with the Failure of Post-operative Rivaroxaban Thromboprophylaxis in Total Knee Arthoplasty Patients: A Retrospective Case-control Study Owais Mian Received Received
  PB-536 Randomized, Double-blinded Phase II Trial of Weight Adjusted versus Standard Dose Enoxaparin Thromboprophylaxis in Hospitalized Cancer Patients at High Risk for VTE Jeffrey Zwicker Received Received
  PB-537 Safety, Tolerability, and Pharmacodynamic Properties of AB002 (E-WE Thrombin), a Recombinant Protein C Activator Thrombin Analog, in Healthy Adult Volunteers Norah Verbout Received Received
  PB-540 The anti-factor XIa antibody BAY 1213790 shows dose-dependent antithrombotic efficacy without an increased risk of bleeding on top of antiplatelet treatment in rabbits Stefan Heitmeier Received Received
  PB-542 Thrombophilia Caused by Methylene Tetrahydrofolate Reductase (MTHFR) Gene C677T Homozygous Mutation Tamar Saralidze Received Received
  PB-543 Racial Differences of Protein S Tokushima and Two Protein C Variants as Genetic Risk Factors for Venous Thromboembolism Hiroko Tsuda Received Received
  PB-544 Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset Ulrike Nowak-Göttl Received Received
  PB-548 Epidemiological Characteristics of Thromboembolism Related to Oral Contraceptives in Japan: Results of a National Survey Kazuko Sugiura Received Received
  PB-549 Genetic and Phenotypic Analyses of Protein S Tokushima and Two Protein C Variants on Healthy Japanese Young Women Kenta Noguchi Received Received
  PB-551 The Risk of Venous Thromboembolism Attributed to Recognized Prothrombotic Genotypes Line H. Evensen Received Received
  PB-555 Predictors of in-Hospital Mortality in Acute Pulmonary Embolism Jose Bonorino Received Received
  PB-556 The Risk of Venous Thrombosis Associated with Elevated Coagulation Factor Levels in the Elderly Huijie Wang Received Received
  PB-557 ABO Blood Type is a Predictor of Venous Thromboembolic Events in Patients with Cancer Simon Mantha Received Received
  PB-559 Incidence and Risk factors of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in African Americans Compared to Whites in Durham County, North Carolina Eva Hortas Received Received
  PB-562 Gender-related differences in venous thromboembolism patients: GARFIELD-VTE Alexander G. G. Turpie Received Received
  PB-563 Genetic variants related to venous thromboembolism. Preliminary results of the first study in an argentinian cohort Federico Aranda Received Received
  PB-565 Prothrombotic genotypes and mortality risk in individuals with and without venous thromboembolism recruited from the general population Line H. Evensen Received Received
  PB-566 Outcomes of Anticoagulation Therapy in Patients by gender - A Single Center Prospective Data Ana Isabel Casanegra Received Received
  PB-568 Protein S Deficiency: Prevalence in Latin-America Cecilia Guillermo Received Received
  PB-569 The Incidence Rate and Distribution of Venous Thromboembolism by Provoking Status in a Racially Diverse Population Aaron Mark Wendelboe Received Received
  PB-570 Underlying co-morbidity explains high levels of protein S in patients with venous thrombosis: results of the MEGA case-control study Deeksha Khialani Received Received
  PB-571 Thrombophilia as an underlying cause for Budd Chiari Syndrome Bushra Moiz Received Received
  PB-576 A systematic review and meta-analysis of the prevalence of venous thromboembolism in patients with sickle cell disease Mosaad Almegren Received Received
  PB-581 Homocysteine screening at the Belfast trust VTE Outpatient Clinic, Northern Ireland Gary Benson Received Received
  PB-582 Twenty-two new mutations identified in Czech patients with antithrombin deficiency Ingrid Hrachovinová Received Received
  PB-586 Risk Factors Associated with Massive PE Praveen Hariharan Received Received
  PB-588 D-dimer, Antithrombin and Thrombin-antithrombin Complex in Deep Vein Thrombosis Usi Sukorini Received Received
  PB-589 Molecular Suitability of the Chacma Baboon Model of Acquired Thrombotic Thrombocytopenic Purpura when Evaluating Anti-VWF Agents Walter Janse Van Rensburg Received Received
  PB-591 Acquired ADAMTS-13 Deficiency in a Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS) Trung Nguyen Received Received
  PB-592 Unsupervised Classification of Multiparametric MRI Correlates with Red Blood Cell, Fibrin and Collagen Content in Murine Model of Venous Thrombosis Olivia R. Palmer Received Received
  PB-598 Linking the anti-inflammatory and anticoagulant properties, the natural inhibitor EcTI impairs the physiopathological aspects of thrombosis Bruno Salu Received Received
  PB-599 ADAMTS13 Levels Correlate with Renal and Inflammatory Markers in Mice with Type 1 Diabetes Mellitus and Nephropathy Michelle Teodoro Alves Received Received
  PB-600 Evaluation of Oral Anticoagulation-associated Intracerebral Hemorrhage Induced by Collagenase VII-S in Rats Roberto Fonseca Received Received
  PB-603 Development of a Novel Acute Model to Evaluate the Effect of Pro-fibrinolytic Compounds in Rabbits Stefan Heitmeier Received Received
  PB-604 Sickle cell trait accelerates fibrin formation and resistance to fibrinolysis in mice and humans Anton Ilich Received Received
  PB-608 Generation of Transgenic Zebrafish with RFP-labeled Young and GFP-labeled Mature Thrombocytes: Analysis of their Lipids Pudur Jagadeeswaran Received Received
  PB-609 The Effect of Antithrombin Budapest3 Mutation for the Heparin Binding Affinity of Antithrombin Krisztina Pénzes-Daku Received Received
  PB-613 Quantification and Analysis of the Interaction Between TLT-1 and Fibrinogen Angelia D. Gibson Received Received
  PB-614 ADAMTS-13: its increase in plasma would have some role in cognitive decline? Luci Dusse Received Received
  PB-616 Clinical Implications of Antivenom Failures to Neutralise Coagulotoxicity of African Snake Venoms Bryan Fry Received Received
  PB-617 The Clinical Implications of the Differential Coagulopathic Effects of Asian Pit Viper Snake Venoms Jordan Debono Received Received
  PB-618 An Overview of Coagulation Disturbances Caused by Australian Elapid Snake Venoms Christina N. Zdenek Received Received
  PB-619 Coagulotoxic Activity in Venoms from Coral Snakes of the Americas (genus: Micrurus) Daniel Dashevsky Received Received
  PB-620 Pathophysiological Implications of Differential Coagulotoxic Effects of Bitis Viper Snake Venoms Nicholas Youngman Received Received
  PB-621 PLXDC2, a Novel Player of the Coagulation Cascade: Results from a Genome Wide Association Study on Plasma FV Levels Florian Thibord Received Received
  PB-622 Monitor Lizard (genus: Varanus) Venoms Disrupt the Clotting Ability of Human Fibrinogen James Dobson Received Received
  PB-623 Effect of Brazilian Snake Venoms on Hemostasis Evaluated by Thrombin Generation Assay Luci Dusse Received Received
  PB-624 The shortened activation peptide of Pseudonaja textilis venom FX confers zymogenicity and resistance to factor VIIIa-IXa activation Mark Schreuder Received Received
  PB-625 Variability in Venom Coagulotoxins in Russell´s Vipers (genus: Daboia) Compromise Antivenom Effectiveness Bianca op den Brouw Received Received
  PB-626 Pseudonaja textilis factor Va retains structural integrity and cofactor function following proteolysis by activated protein C Mark Schreuder Received Received
  PB-627 The Glycan Structure on Factor XIII B Subunit László Muszbek Received Received
  PB-630 Polyphosphate-induced Thrombosis is Enhanced in Mice Deficient in Histidine-rich Glycoprotein Rida Malik Received Received
  PB-631 Hydrogen-deuterium Exchange (HDX) Mass Spectrometry Highlights Conformational Changes Induced by FXI Activation and Binding of FIX to FXIa Awital Bar Barroeta Received Received
  PB-632 FRET-based Assays for the Quantitation of (pro)Thrombin Binding to Factor XI Awital Bar Barroeta Received Received
  PB-633 Identification of the Histidine-rich Glycoprotein Domain Responsible for its Inhibition of Factor XIIa Tammy Truong Received Received
  PB-636 Role of N-glycosylation on the Secretion, Plasma Levels and Function of Factor XII: Results from Patients with Congenital Disorders of Glycosylation and a Recombinant Model Maria Eugenia de la Morena-Barrio Received Received
  PB-637 A novel antithrombotic coating for blood-contacting medical devices Lucia Musumeci Received Received
  PB-641 Plasma kallikrein contributes to coagulation by activating factor IX Mayken Visser Received Received
  PB-642 Potential Contribution of Kallikrein to the Coagulation System Independent of Factor XII Activation Juliet Butler Received Received
  PB-644 Misfolded Proteins Can Differentially Modulate the Contact System Lewis Hardy Received Received
  PB-646 Biorelevant Polyanions Modulate the Structure and Stability of Fibrin in a Size-, and Charge-dependent Manner Krasimir Kolev Received Received
  PB-647 Structure, Assembly and Dissociation of Plasma Coagulation Factor XIII Complex Arijit Biswas Received Received
  PB-648 Impact of Fibrinogen Post-translational Modifications on its Structure and Function Žofie Sovová Received Received
  PB-649 Defining the Functional Role and Regulatory Mechanism of Fibrinogen Phosphorylation in Inflammation and Thrombosis Kingsley R Simpson Received Received
  PB-651 Interpretation of Maximum Absorbance Data Obtained from Turbidimetry in Plasma Samples Marlien Pieters Received Received
  PB-654 Genetic abnormalities of Japanese patient with symptomatic- and asymptomatic-dysfibrinogenemia Shogo Tamura Received Received
  PB-655 Intra-assay reproducibility of a precalibrated liquid Clauss fibrinogen assay Audrey Carlo Received Received
  PB-656 Fibrin-derived (ß40-66)2 fragment promotes endothelial permeability via the VLDL receptor dependent pathway Sergiy Yakovlev Received Received
  PB-657 Acquired factor XIII deficiency in patients under treatment with plasmapheresis: a poorly explored etiology Fernando Chuliber Received Received
  PB-658 Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement Qiulan Ding Received Received
  PB-663 A chemical screen identifies small molecule modulators of fibrinogen production and experimental venous thrombosis Rui Vilar Received Received
  PB-664 Both Hemorrhagic and Thrombotic Complications in a patient with Anti-Factor XIII Autoantibody; Characterization of the Antibody Julien Bovet Received Received
  PB-666 Improved specificity and performances of a novel photometric automated assay for Factor XIII activity Claire Dunois Received Received
  PB-667 Conditions Associated with Low tPA Activity Are Prevalent among Patients with Schizophrenia or Schzoaffective Disorder Silvia Hoirisch-Clapauch Received Received
  PB-673 Thrombin-cleaved Osteopontin Enhances B16 Melanoma Growth John Morser Received Received
  PB-674 New functions of prelatent antithrombin Vicente Vicente García Received Received
  PB-677 Heparanase: a potential new factor concerned to epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma Massoud Mirshahi Received Received
  PB-678 Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients Massoud Mirshahi Received Received
  PB-679 The Evaluation of the Joint Status of Hemophiliac Adults: Single Center Adult Hematology Clinic Experience Salih Aksu Received Received
  PB-680 Response to Recombinant FVIIIC Therapy in a Young Haemophilia A Patient with Spiral Fracture of the Left Femur Wuraola A. Shokunbi Received Received
  PB-682 Interim Analysis of Effectiveness of Intraarticular Injection of Mononuclear Stem Cells in Hemophilia Patients with Joint Arthropathy: Two Case Reports Mehran Karimi Received Received
  PB-683 A Comparison of Haemostatic Response to Recombinant and Plasma-derived Factor VIII Concentrates in Patients with Hemophilia A Natalia Silina Received Received
  PB-685 Pharmacokinetic Study of F? in Chinese Boys with Hemophilia Huang Kun Received Received
  PB-687 Efficacy of Short-term Individualized Prophylaxis Guided by PK and Joint Evaluation in Chinese Adult Patients with Severe Hemophilia A Xueyan Sun Received Received
  PB-688 Use of Lower Dose of Extended Half-life rFVIIISE (Rurioctocog Alfa Pegol) Satisfies Prophylactic Purpose in Hemophilia A Hugh Kim Received Received
  PB-695 Clinical and Laboratory evaluation of female carriers of hemophilia Mariana S. Pastori Received Received
  PB-697 A United States Multi-Center Analysis of Characteristics Associated with Prescribed Factor Prophylaxis Duc Tran Received Received
  PB-703 Final data from the Italian Registry on intracranial haemorrhage in haemophilia patients: EMO.REC Registry (2009-2018) Ezio Zanon Received Received
  PB-705 Ideal Body Weight Is Proven Most Reliable to Dose Factor VIII Concentrate in Overweight and Obese Hemophilia A Patients Iris van Moort Received Received
  PB-706 Development of a Population Pharmacokinetic Database for Coagulation Factor VIII Octocog Alfa (Advate®) in Taiwan, and Preliminary Assessment of Pharmacokinetic Parameters in Taiwanese Adults Yeu-Chin Chen Received Received
  PB-707 High risk of intracranial haemorrhage in adult mild haemophiliac patients: data from the EMO.REC Registry Ezio Zanon Received Received
  PB-710 Emicizumab Improves Factor X Activation and Thrombin Generation Similar to Mild Hemophilia in Persons with Hemophilia A and Inhibitors Marilyn Manco-Johnson Received Received
  PB-711 The difference of bleeding frequency and hemophilic arthropathy between hemophilia A and hemophilia B patients Shixuan Wang Received Received
  PB-712 Incidence, Presentation and Management of Pseudotumors in Hemophilics: A systemic Review Romana Akbar Received Received
  PB-713 Impact of low dose prophylaxis vs. on demand treatment in severe hemophilia A patients in Pakistan Munira Borhany Received Received
  PB-714 The Relationship between coagulant activity (FVIII levels and Thrombin Generation Assay) and structural evidence of joint disease in patients with mild to moderate haemophilia A Mike Laffan Received Received
  PB-716 Clinical validation of population pharmacokinetic model for plasma-derived factor VIII/VWF using WAPPS-Hemo Santiago Bonanad Received Received
  PB-722 Real Life Experience in a Portuguese Haemophilia Center After Switching to rFVIII-Fc: the First Results Cristina Catarino Received Received
  PB-725 HOSPITALIZATION OF HEMOPHILIA A and B PATIENTS IN BRAZIL - TRENDS FROM 2004 TO 2016 Ana C. Guersoni Received Received
  PB-726 The Impact on Australian Haemophilia Nursing Roles after the Introduction of an Interim Agreement of Extended Half Life Products for the Treatment of Haemophilia Robyn Shoemark Received Received
  PB-727 ADVANCE-AF: An international, prospective, longitudinal, observational registry study of hemophilia patients with atrial fibrillation Roger Schutgens Received Received
  PB-731 Case report: A rare case of concomitant sickle cell disease and haemophilia A with development of a high titre factor VIII inhibitor Sharon Allen Received Received
  PB-735 HaemoValue: Development of a Set of Outcomes for Measuring Value in Persons with Haemophilia Erna Van Balen Received Received
  PB-737 Exploring the Wider Value of Extended Half-life Products in Haemophilia: A Targeted Literature Review Anum Shaikh Received Received
  PB-738 The First Chinese Hemophilia Individualized Prophylaxis Study (CHIPS): Improvement in Health-related Quality of Life (HRQoL) CHO-KLAT Scores in Boys with Severe Hemophilia A in China YUAN LI Received Received
  PB-739 Development and Validation of a Population Pharmacokinetic Model for rAHF-FL-PEG (Adynovate): A Report on behalf of the WAPPS-hemo Investigators ad hoc Subgroups Alfonso Iorio Received Received
  PB-742 Effect of Lower von Willebrand Factor and Factor XI Levels on Treatment Success of the Levonorgestrel Intrauterine System or Endometrial Ablation in Heavy Menstrual Bleeding - An Explorative Study Karina Meijer Received Received
  PB-745 Burden of Rare Bleeding Disorders on Blood Transfusion Services: A Developing Country Perspective Anila Rashid Received Received
  PB-747 Prekallikrein and High Molecular Weight Kininogen Deficiency in Oman: A Challenging Diagnosis in Mucosal Bleeding Hanan Nazir Received Received
  PB-748 Thrombin Generating Potential, Plasma Clot Formation and Clot Lysis Are Impaired in Patients with Bleeding of Unknown Cause Stefanie Hofer Received Received
  PB-749 Demographic and Clinical Data of Afibrinogenemic Patients from the QualyAFIB Study Claudia Khayat Received Received
  PB-751 Evaluation of GGCX Missense Mutations Effect on Vitamin K Dependent Proteins Identified in VKCFD1 Patients by a New Assay and in Silico Modeling Suvoshree Ghosh Received Received
  PB-752 Archeogenetics of the p.Cys38Arg Variant Associated with FXI Deficiency: A 5,400 Years Old Mutation Identified in Different Southwestern European Countries Maria Eugenia de la Morena-Barrio Received Received
  PB-753 Congenital Factor VII Deficiency: Epidemiology, Clinical Characteristics and Management. Experience of the Northern Greece Hemophilia Center Vasileia Garypidou Received Received
  PB-755 CONGENITAL FACTOR XI DEFICIENCY, INHIBITOR AND CLOT FORMATION Erica Scalambrino Received Received
  PB-756 Genetic profile and clinical management of Rare Bleeding Disorders: Across the province of Sindh, Pakistan Munira Borhany Received Received
  PB-757 Genetic characterization of congenital fibrinogen disorders in Polish patients - clinical phenotype and follow-up Anetta Undas Received Received
  PB-760 A nightmare in congenital factor XIII deficiency:Inhibitor development with severe bleeding Serap Karaman Received Received
  PB-762 A rare case of bleeding in early postpartum due to Factor XII deficiency Melen Brinza Received Received
  PB-763 A Heterozygous FGB Variant Causing Hypofibrinogenemia in a Swedish Family Marcus Fager Ferrari Received Received
  PB-767 Improving Prevalence Data on Rare Bleeding Disorders Using A Bleeding Disorders Registry Nur Insyirah Abdul Kadir Received Received
  PB-771 DELPHI expert consensus statements on clinical evaluation of bleeds in patients with acquired haemophilia Andreas Tiede Received Received
  PB-773 Acquired Factor XI deficiency: diagnosis and evolution. A case reports Marina Sol Lopez Received Received
  PB-777 Rare Bleeding Disorders in Lebanon: Clinical and Molecular Data and Creation of a Registry Roula Farah Received Received
  PB-778 Factor XIII Deficiency. A Case Report at Hospital Infantil de México Federico Gómez Aida Mashenka Moreno González Received Received
  PB-779 Hypodysfibrinogenemia in a Patient with Aortic Valve Thrombosis and Stroke: Diagnosis and Evolution. Identification of a Novel Heterozygous Fibrinogen Gamma Chain Mutation Veronica Privitera Received Received
  PB-780 vWF Activity is Associated with Bleeding Symptoms in Essential Thrombocythemia Jun Yamanouchi Received Received
  PB-782 Low von Willebrand Levels Do Not Predict Bleeding in Children Undergoing Tonsillectomy Veronica Flood Received Received
  PB-783 Bleeding Symptoms and von Willebrand Factor Levels in Thai Patients: 30-year Experience in a Tertiary Care Center Chaphatai Moonla Received Received
  PB-785 Investigation of the Epidemiology of VWD in Patients Attending the Royal Hospital, Muscat, Oman Rashid Al Ghaithi Received Received
  PB-786 Desmopressin Plasma Concentration Does Not Correlate with VWF and FVIII Response in von Willebrand Disease Jessica Heijdra Received Received
  PB-787 The Management of Patients with von Willebrand Disease (VWD) Undergoing Surgery by Using a Pure Plasma Derived VWF is Easy, Efficient and Safe Jenny Goudemand Received Received
  PB-788 Effect of pathologic flow on von Willebrand factor cleavage by ADAMTS13 Maria Bortot Received Received
  PB-789 Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing Andreas Straub Received Received
  PB-790 Exploration and treatment strategies for gastrointestinal bleeding in VWD over a 3-year period: A national survey from the French reference center for VWD Antoine Rauch Received Received
  PB-791 Genotype-phenotype and pathophysiological mechanisms involved in patients with von Willebrand disease (VWD) type 2A and 2M according to domains affected by genetic clinical-grade variants (CGV) Adriana Inés Woods Received Received
  PB-792 Gastrointestinal Angiodysplasia and Von Willebrand Disease: Our Experience of Managing Challenging Bleeding Gary Benson Received Received
  PB-793 A Novel Mechanism in Severe Type 1 VWD: a Heterozygous Splicing Mutation Causes Exon 26 Skipping and Increases VWF Clearance Mattia Ferrarese Received Received
  PB-794 Annual Bleeding Rates with Efficacy/Safety of the VWF Concentrates used On Demand or under Secondary Long-Term Prophylaxis in a large cohort of centrally confirmed VWD3 patients: results of 24-month prospective observation in 169 cases enrolled into the 3 Augusto B Federici Received Received
  PB-795 Successful non-surgical management and use of thrombopoietin receptor agonist in a case of spleen injury in a young girl with von Willebrand disease type 2B Valerie Proulle Received Received
  PB-796 Pathophysiology underlying genetic clinical-grade variants (CGV) responsible for the phenotypes type 2A and 2M of von Willebrand disease (VWD) Adriana Ines Woods Received Received
  PB-797 Platelet Transfusion in von Willebrand Disease type IIB in a Family with Normal Platelet Counts Kim Schafer Received Received
  PB-798 Variable Reproducibilty of Type 2 VWD Diagnoses Veronica Flood Received Received
  PB-800 Type 1 VWD Caused by a Novel Dominant p.Thr274Pro Mutation Localized in VWF Propeptide Maria Teresa Pagliari Received Received
  PB-802 BMI is an important determinant of VWF and FVIII levels in patients with von Willebrand disease Ferdows Atiq Received Received
  PB-806 Acquired type 3-like von Willebrand syndrome complicated with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia Jie Yin Received Received
  PB-807 Management of Postpartum Haemorrhage in a Woman with Type 2B Von Willebrand Disease Samuel Ackroyd Received Received
  PB-812 Quantification of VWF Propeptide Release before and after Desmopressin in von Willebrand Disease and Hemophilia A Jessica Heijdra Received Received
  PB-814 Sequencing of VWF Gene in Patients with von Willebrand Disease: Our First Experience in Slovakia Jana Zolkova Received Received
  PB-815 Acquired von Willebrand syndrome and hematological malignancies Yamina Ouarhlent Received Received
  PB-816 Detecting Structural Disorder in Multimeric von Willebrand Factor Matthew Auton Received Received
  PB-817 Von Willebrand Disease: An International Survey Assessing Important Topics for Decision-making Nathan T. Connell Received Received
  PB-818 DDAVP Challenge Test in Patients with von Willebrand Disease Type 1 (VWD1) and Low von Willebrand Factor (Low VWF): Analysis of 616 Patients Mara Agazzoni Received Received
  PB-822 Some Haemostatic Parameters, Full Blood Count and Relative Plasma Viscosity of Blood Donors in Calabar Metropolis Dorathy Chioma Okpokam Received Received
  PB-825 Comparison of mindset between the medical doctors and the staffs of genetic counseling about support of hemophilia carriers in Japan Tomie Fujii Received Received
  PB-826 THE EFFECT BETWEEN BANGUN-BANGUN LEAVES ETHANOL EXTRACTS (EDBB) AND CARROTS JUICE (CJ) AS ANALGETIC ON MICE INDUCED BY ACETIC ACID Yunita Sari Pane Received Received
  PB-827 It takes a village… The implementation of a multidisciplinary clinic review for children and adolescents with bleeding disorders Jaime Chase Received Received
  PB-828 Current Nursing Workloads and Implications for the Future within Haemophilia Treatment Centres in Australia Susan Jane Webzell Received Received
  PB-829 National benchmarking of Paediatric Haemophilia Treatment Centres Stacey Hutchison Received Received
  PB-830 The nurse´s role in training others to administer missing factor concentrates to patients with haemophilia Pawel Laguna Received Received
  PB-832 Ichec: Refining the Pediatric Bleeding Assessment Tool Karin Fijnvandraat Received Received
  PB-833 MYH9 Related Disease Mimicking Immune Thrombocytopenia Bunchoo Pongtanakul Received Received
  PB-835 Does a Therapeutic Early Morning ACT and APTT Correlate with the Absence of Bleeding or Thrombotic Complications within the Next 24 Hours in Paediatric Patients on ECMO? Gabrielle Lee Received Received
  PB-836 Circumcision Experience in Children with Bleeding Disorder: Samsun Circumcision Protocol Canan Albayrak Received Received
  PB-837 A Development of Anaphylactoid Reaction in a Child with Congenital FVII Deficiency and Inhibitor: The First Reported Case Aysegul Unuvar Received Received
  PB-838 Hypofibrinogenemia: A novel long deletion of the fibrinogen beta chain causing mucocutaneous bleeding Darintr Sosothikul Received Received
  PB-839 Kasabach-Merritt phenomenon in an infant: Tufted angioma or kaposiform hemangioendothelioma Rumeysa Tuna Received Received
  PB-841 Impact of Hematology Involvement on Adolescents Admitted for Acute Heavy Menstrual Bleeding Viia Anderson Received Received
  PB-842 Acquired von Willebrand Syndrome (aVWS) - A Complication in Pediatric Patients with Congenital Heart Diseases Ivonne Wieland Received Received
  PB-843 Hemostasis Dysfunctions in Routine Otolaryngology Preoperative Laboratory Screening Tests - An One Year Retrospective Pediatric Study Rute Preto Received Received
  PB-845 Therapeutic Aspects, Determining the Outcome of Deep Veins Thrombosis (DVT) in Children with Hematological Diseases Darya Fedorova Received Received
  PB-846 Genetic and Clinical Determinants Influencing Warfarin Dosing in Thai Children and Adolescents Premmika Intapun Received Received
  PB-847 Septic Dural Sinus Thrombosis in Children Patcharee Komvilaisak Received Received
  PB-848 Central Venous Catheter-associated Thromboembolism: Still a Frequent Complication with No Reliable Predictive Indicators in Young Children with Diabetic Ketoacidosis Gary Woods Received Received
  PB-849 Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-analysis Leonardo R. Brandão Received Received
  PB-851 Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation? Anne Demulder Received Received
  PB-854 Neonatal and Pediatrics Optimal Anticoagulant Therapy and Role of Clinical Pharmacist - A Medication Safety Model in Developing Country Gul Ambreen Received Received
  PB-855 Predictive Value of D-dimers in the Diagnosis of Suspected Acute Limb Deep Vein Thrombosis in Children: A Prospective Study Maria Laura Avila Received Received
  PB-857 Thromboembolism and Bleeding in Congenital Diaphragmatic Hernia Leonardo Brandao Received Received
  PB-858 Highly Discordant Laboratory-based Aspirin Resistance Rates after Pediatric Organ Transplantation May Reflect Significant Cyclooxygenase 1-independent Thromboxane Production Postoperatively Lori Luchtman-Jones Received Received
  PB-859 Bleeding and Clotting in Children on ECMO at the Royal Children´s Hospital: A Two Year Summary Suelyn Van Den Helm Received Received
  PB-860 Comparison of alpha-1-antitrypsin glycoform content in newborns and adults Helen Atkinson Received Received
  PB-861 Platelet Phenotype and Function in Paediatric Extracorporeal Membrane Oxygenation (ECMO) Circuits Hui Ping Yaw Received Received
  PB-862 Endothelial and Platelet Activations in a-thalassemia Diseases Pankamol Sirivadhanakul Received Received
  PB-864 Transition of Care for Adult and Pediatric Patients with Venous Thromboembolism - An American Thrombosis Hemostasis Network (ATHN) Project Maria DeSancho Received Received
  PB-866 Single Nucleotide Polymorphisms in Promoter Region of PROC gene are Associated with Low Protein C Activity but not Increase Risk of Thromboembolism in Pediatric Population Natsumon Udomkittivorakul Received Received
  PB-867 Use of antithrombin concentrate in acquired antithrombin deficiency in acutely unwell children receiving unfractionated heparin -single centre experience Deepa Jayakody Arachchillage Received Received
  PB-868 First Korean Case of Thrombocythemia 1 (THCYT1) with THPO Mutation (c.13+1G>A, splicing) Diagnosed by Targeted Exome Sequencing Do-Hoon Kim Received Received
  PB-869 Comparison of the thromboelastographic profile of paired placental and neonatal blood samples Erica Scalambrino Received Received
  PB-870 Cerebral Sinus Venous Thrombosis In One Institution Patcharee Komvilaisak Received Received
  PB-872 Low dose anticoagulation in children with Kawasaki disease and large coronary artery aneurysms: our experience at Chandigarh, North India Surjit Singh Samlok Received Received
  PB-874 A Retrospective Review of Antithrombotic Therapy in Paediatric Patients with Moyamoya Disease Nadia Poci Received Received
  PB-875 Thrombotic Events in Very Low Birth Weight Infants Treated in an Intensive Care Setting Athis Arunachalam Received Received
  PB-876 Low Bone Mass/Osteoporosis in Thai Children and Adolescents Taking Long-term Warfarin Thanyabun Akkharawanasakul Received Received
  PB-878 Multidisciplinary Approach to Pediatric Thrombosis; Istanbul Pediatric Thrombosis (I-PeT) Study Group Experience Zeynep Karakas Received Received
  PB-879 Symptomatic and Incidental VTE in Children Differs in Epidemiology and Outcomes Daria Fedorova Received Received
  PB-880 Results of an International Survey of Practice in the Diagnosis And Management of Pediatric Pulmonary Embolism Madhvi Rajpurkar Received Received
  PB-881 Thrombolytic Therapy in Preterm Neonates: experience of a single center Priscila Grizante-Lopes Received Received
  PB-882 Congenital protein C deficiency: a family report from Argentina David A. Veron Received Received
  PB-883 Inferior vena cava filters (IVCF) in children with venous thromboembolism (VTE): a 26-year prospective cohort from a single tertiary center in Argentina Carolina Cervio Received Received
  PB-885 Prothrombotic states as a risk factor for stroke among pediatric patients Olivera Serbic Received Received
  PB-887 Hemostatic Complications in Pediatric Extra Corporeal Membrane Oxygenation: the Role of Rotational Thromboelastometry Joppe Geert Frederik Drop Received Received
  PB-888 Congenital Protein C Deficiency: Unfamiliarity of this Condition led to Unfavorable Results in a 14 Year old Girl Madlen Reschke Received Received
  PB-890 The impact of the volume of mediastinal lymphadenopathy on venous thromboembolism in children with lymphoma Daria Fedorova Received Received
  PB-891 Analysis of Stroke in Neonates and Children: Single Center Experience Hale Ören Received Received
  PB-892 Enriched Variants of Coagulation, Platelet and Related Genes are Common in Adolescents with Idiopathic Occlusive Proximal Deep Vein Thrombosis Beth Warren Received Received
  PB-894 Neonatal Inferior Vena Cava Syndrome: An Evidence-based Systematic Review of the Literature Paul Thuan Tieu Received Received
  PB-895 Incidence and Risk Factors for Peripherally Inserted Central Catheter-related Venous Thrombosis in Critically-ill Children with Cardiac Disease: A Retrospective Single-center Case-control Study Eva Hortas Received Received
  PB-896 Use of Low Molecular Weight Heparins in Pediatric Thromboembolism: A Retrospective Descriptive Study Sarah Brouche Received Received
  PB-897 A 10-year Case-control Study on the Risk Factors for Neonatal Portal Vein Thrombosis Tuan Nguyen Received Received
  PB-898 An Institutional Analysis of Pediatric Patients with Upper Extremity Deep Vein Thrombosis in the Context of Thoracic Outlet Syndrome Aamir Ameen Sholapur Received Received
  PB-899 Clinical Course of Lemierre Syndrome in the Contemporary Era: Results of a Patient-level Analysis of 715 Patients Luca Valerio Received Received
  PB-900 Monitoring of Thromboprophylaxis in Children with Fontan Procedure: Experience in an Argentinian Hospital Silvina Romano Received Received
  PB-902 International Pediatric Thrombosis Network: Advancing the Field of Pediatric Thrombosis C.Heleen van Ommen Received Received
  PB-904 The Effect of Hyperbilirubinemia and Phototherapy on Apoptotic, Platelet-derived, Endothelial-derived, and Tissue Factor Positive Microparticle Levels in Neonates Hale Ören Received Received
  PB-905 Development of an Umbilical Cord and Pediatric Plasma Bank Helen Atkinson Received Received
  PB-906 Pediatric May-Thurner Syndrome - A Systematic Review Leonardo Brandao Received Received
  PB-908 Effective and Well Tolarated Treatment with a Direct Oral Anticoagulant in a Young Patient with the Vena Cava inferior Agenesis and a Deep Vein Thrombosis Tomas Kuhn Received Received
  PB-909 Anticoagulation Management and Outcomes in Thrombocytopenic Cancer Patients with Atrial Fibrillation Avi Leader Received Received
  PB-910 Safety of Using Antiplatelet Drug in Dengue Hemorrhagic Fever with Thrombocytopenia: A Retrospective Study Andree Kurniawan Received Received
  PB-914 Major bleeding after a gynecological operation in patient with essential thrombocythemia - Case report Marija Skoko Received Received
  PB-915 Reduced platelet function in patients with liver cirrhosis Andrea Artoni Received Received
  PB-917 Concomitant Immune Thrombocytopenia and Positive for JAK2 V617F Mutation in a Patient: Case Report and Literature Review Xiaofan Liu Received Received
  PB-919 Using flow cytometry to improve the risk assessment and management of bleeding in subjects with acquired thrombocytopenia David Connor Received Received
  PB-921 Platelet disorders, acquired with thermally oxidized mixed vegetable oils in low and high doses - In animal model Gul Ambreen Received Received
  PB-926 Whole Blood Mepacrine Flow Cytometric Determination of Platelet Dense Granules: Difficulties in Establishing a Reference Range and Interpreting Results Timothy Brighton Received Received
  PB-927 Whole Mount Electron Microscopy for Determination of Platelet Dense Granules: Which Parameter to Measure to Detect Dense Granule Deficiency? Timothy Brighton Received Received
  PB-928 The First Homozygous GNE Variant in the P-loop of the ManNAc Kinase Domain Causes Severe Macrothrombocytopenia and Bleeding Marie-Christine Morel-Kopp Received Received
  PB-929 Outcome of an Enhanced Diagnostic Pipeline for Patients Suspected for Inherited Thrombocytopenia Eva Leinoe Received Received
  PB-930 Prospective Comparison of Whole Mount Electron Microscopy and Mepacrine Based Flow Cytometric Assay for Determination of Platelet Dense Granules and Platelet Dense Granule Deficiency Timothy Brighton Received Received
  PB-932 How Many Shades of Grey in the Gray Platelet Syndrome Marie-Christine Morel-Kopp Received Received
  PB-933 Whole Exome Sequencing for Diagnosis of Hereditary Platelet Disorders Ponlapat Rojnuckarin Received Received
  PB-934 Integrin ß3 Deficiency Disrupts Triglyceride (TG) Metabolism Owing to an Impaired Lipoprotein Lipase (LPL) Secretion Xiaodong Xi Received Received
  PB-937 Glycoprotein VI Mutation is Widespread in the Chilean Population Amanda Dalby Received Received
  PB-939 First Spanish Registry of Inherited Platelet Disorders [RETPLAC] Jose Rivera Received Received
  PB-941 MYH9 Disorders in Thailand: Pediatric Case Series from Thai Macrothrombocytopenia Study Group Rungrote Natesirinilkul Received Received
  PB-942 MYH9 gene mutation screening in students with macrothrombocytes/ thrombocytopenia who are attending in hearing impaired schools in Istanbul Tiraje Celkan Received Received
  PB-944 Platelet Function Testing: Current Practice among Clinical Centers in the Nordic Countries Riitta Lassila Received Received
  PB-945 The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume David Connor Received Received
  PB-946 Correlation between mutations and clinical features in patients with essential thrombocythemia Mankai Ju Received Received
  PB-949 Studies on Regulation of Thromboxane Production by PCTP and RUNX1 in Megakaryocytic cells A Koneti Rao Received Received
  PB-950 Capillary Blood Reference Intervals for Platelet Counts (PLT) and Related Parameters from Full Term Healthy Neonates in China and Influences of Gender, Gestational Age and Postnatal Age on PLT Qun Hu Received Received
  PB-951 Reported Outcome and Quality of Life of Children with Chronic Immune Thrombocytopenia Treated with Thrombopoietin Receptor Agonist Nongnuch Sirachainan Received Received
  PB-952 Assessment of Platelet Aggregation in Umbilical Cord Blood Using Multiple Electrode Aggregometry Sara Joan Israels Received Received
  PB-953 Targeting DNT/Treg axis, Sirolimus is operative in thrombocytopenia caused by autoimmune lymphoproliferative syndrome (ALPS)/ALPS-like syndrome: results of a single centre experience Hao Gu Received Received
  PB-954 Aspirin Unresponsiveness in Pediatric Patients: Incidence and Methods of detection Darintr Sosothikul Received Received
  PB-956 Immune Thrombocytopenia in Childhood: A 15 Year Single Center Experience Alkistis Adramerina Received Received
  PB-958 Post-translational polymodification of the C-terminal Tail of TubB1 Regulates Motor Protein Activity in Platelet Production and Function Neil Morgan Received Received
  PB-959 Impact of intracellular calcium imbalance in megakaryocytic leukaemia cells uncovered through the deletion of NMDA receptors James Hearn Received Received
  PB-960 Human Bone Marrow Primary Endothelial Cells Play a Key Role in the Latest Phase of Megakaryocyte Differentiation Anita Eckly Received Received
  PB-961 TLT-1 Expression during Megakaryocyte Differentiation Angela Doerr Received Received
  PB-965 Potential of anthocyanins to reduce thrombotic risk by alleviating platelet activity Almottesembellah Gaiz Received Received
  PB-967 Perfusion Conditions Control the Morphology of Thrombus Growth at High Shear Rates Shunichi Kobayashi Received Received
  PB-968 Evaluation of Platelet Membrane Potential in Assessing the Risk of Thrombosis in Patients with Chronic Myeloproliferative Neoplasms Viola Popov Received Received
  PB-970 The Effect of Procoagulant Platelets on Different Aspects of Hemostasis Sofia Ramstrom Received Received
  PB-974 Do donor attributes influence platelet quality following ex vivo storage? Dianne E. Van Der Wal Received Received
  PB-975 Variation of platelet dependent thrombin generation in phenotypes of acute venous thromboembolism Marina Panova-Noeva Received Received
  PB-976 A Synthetic Triple Helical Collagen Peptide as a New Agonist for Flow Cytometric Measurement of GPVI Specific Platelet Activation Yaqiu Sang Received Received
  PB-977 A novel rapid method of red blood cells and platelets permeabilization and staining for flow cytometry analysis Marie-Christine Alessi Received Received
  PB-979 Platelet-specific factor XIII-A: A novel role in the regulation of platelet function Jo Mitchell Received Received
  PB-983 Platelet storage lesion: Proteomic analysis of extracellular vesicles derived from platelets treated with Mirasol Maria N. Barrachina Received Received
  PB-984 Platelet size subpopulations differ in protein constitution and mRNA profile Aneta Wrzyszcz Received Received
  PB-985 The Role of Platelet Membrane Fluidity in Expressions of Platelet Receptors and Platelet Derived Microparticles in Patients with Chronic Myeloproliferative Neoplasms Viola Maria Popov Received Received
  PB-986 Synergy in Platelet Activation and Thrombus Formation in Mice with a Combined Deletion of PECAM-1 and Ceacam1 Fahd A. Kuriri Received Received
  PB-987 Human Fc?RIIa receptor contributes to E.coli-induced thrombocytopenia in vivo Dermot Cox Received Received
  PB-988 Heme induces platelet aggregation via two ITAM receptors: implications in rhabdomyolysis-induced acute kidney injury Nagaharu Tsukiji Received Received
  PB-989 Metabolomics of platelet activation with normoxia and hypoxia Nathan Clendenen Received Received
  PB-992 Coenzyme Q10 Attenuates Platelet Function through Targeting cAMP/PKA Pathway Yan Yang Received Received
  PB-993 The Differential Requirement of the Btk Kinase Domain Downstream of ITAM and HemITAM Signalling Sophie H Nock Received Received
  PB-994 Evidence for a PI3-kinase-independent pathway regulating ADP-induced Rap1b activation in platelets Carol Dangelmaier Received Received
  PB-995 Branched-Chain Amino Acids Facilitated Thrombosis by Enhancing the Propionylation of TMOD3 in Platelets Yanyan Xu Received Received
  PB-996 Effect of recombinant human lactoferrin, isolated from transgenic goats, on platelet aggregation and Ca2+-response Ekaterina Shamova Received Received
  PB-999 Platelet Integrin aIIbß3-dependent Outside-in Signaling Is Regulated by Apoptosis Signal-regulating Kinase 1 through p38 MAP Kinase Signaling Meghna Naik Received Received
  PB-1000 Fibrin modulates shear-induced NETosis in sterile occlusive thrombi formed under arterial hemodynamic flow Scott Diamond Received Received
  PB-1001 Characterization of the P-selectin-TLT-1 Null Mouse A. Valance Washington Received Received
  PB-1002 The VWF-GPIb interaction mediates thrombo-inflammation in experimental stroke via recruitment of monocytes, neutrophils and T-cells to the brain Frederik Denorme Received Received
  PB-1003 Effect of Ultrapure Bacterial Lipopolysaccharides on the Modulation of Platelet Activation Thomas Vallance Received Received
  PB-1004 The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice Sakthivel Vaiyapuri Received Received
  PB-1005 Platelet Rich Plasma for Acute Achilles Tendon Rupture: A Double-Blind Multicentre Randomized Placebo-controlled Trial (PATH-2) Paul Harrison Received Received
  PB-1008 Inferior Vena Cava Filters in Cancer Patients: Indications and Outcome Anila Rashid Received Received
  PB-1009 A Comparison of Venous Thromboembolism (VTE) and Arterial Events between Ixazomib, Lenalidomide and Dexamthosone (ILD) and Lenalidomide and Dexamethosone (LD) Chemotherapy in Multiple Myeloma: Single Centre Experience Zara Sayar Received Received
  PB-1010 Risk of Upper Limb Venous Thromboembolism from Peripherally Inserted Catheters in Cancer Patients Receiving Chemotherapy Hiu Lam Agnes Yuen Received Received
  PB-1011 A Case of Cryocrystalglobulinemia with Microvascular Embolization as the First Manifestation and Literature Review Ning Tang Received Received
  PB-1012 Patients with Primary CNS Lymphoma Have High Rates of Venous Thromboembolism during R-MPV Chemotherapy Hiu Lam Agnes Yuen Received Received
  PB-1014 Coagulation Factors and Natural Anticoagulants in Polycythemia Vera Patients, Relation with JAK2V617F Mutation Load Natalya Silina Received Received
  PB-1015 Improving Care for Patients with Cancer Associated Thrombosis in the Netherlands Using Patients´, Caregivers´ and Health Care Professionals´ Experiences Asiong Jie Received Received
  PB-1017 Thromboprophylaxis in the Perioperative Patient in Patients with Breast Cancer on Tamoxifen Beverley Hunt Received Received
  PB-1018 Risk of Venous Thromboembolism in Hospitalized Medical Cancer Patients with Midline and Peripherally Inserted Central Catheters Scott Kaatz Received Received
  PB-1019 Management of Superficial Venous Thrombosis in Unevaluated Situations: Cancer, Severe Chronic Renal Failure, Pregnancy and Post-partum Laurent Bertoletti Received Received
  PB-1020 Venous Thromboembolism in Hospitalized Medical Cancer Patients with and without Chemotherapy Infusion through Peripherally Inserted Central Catheters Scott Kaatz Received Received
  PB-1021 Accuracy of the Ottawa Score in Risk Stratification of Recurrent Venous Thromboembolism in Patients with Cancer-associated Venous Thromboembolism. A Systematic Review and Meta-analysis Aurelien Delluc Received Received
  PB-1022 Clinical Risk Prediction Model for Venous Thromboembolism (VTE) in Allogeneic Blood or Marrow Transplant (BMT) Survivors Radhika Gangaraju Received Received
  PB-1024 Evaluation of Outpatient Management in Patients with Cancer-associated Venous Thromboembolism Stephan V. Hendriks Received Received
  PB-1027 Global assays (TEG and ETP) and biomarkers in stratifying thromboembolic risk in patients with lung and gastrointestinal cancer undergoing chemotherapy or chemoradiotherapy - a subsequent analysis from the BIOTEL (lung cancer) and BIOTEGIC (gastrointestin Nora Lee Received Received
  PB-1028 Association of complete blood count parameters, d-Dimer and soluble P-selectin with risk of arterial thromboembolism in patients with cancer Ella Grilz Received Received
  PB-1029 Relative Risk of Arterial and Venous Thromboembolism in Persons with Cancer versus Persons without Cancer - A Nation-Wide Analysis Ella Grilz Received Received
  PB-1030 Apixaban as treatment for Cancer Related Venous Thrombosis - A single arm interventional study Trine-Lise Hannevik Received Received
  PB-1031 Superficial Vein Thrombosis and Cancer Jana Hirmerova Received Received
  PB-1035 Thromboses in Hodgkin Lymphoma Are Caused by Acquired Risk Factors Nilgun Sayinalp Received Received
  PB-1036 Von Willebrand Factor Levels Are Increased in Polycythemia Vera and Can Be Predicted by Erythrocyte Counts Monica Sacco Received Received
  PB-1037 The Ottawa score does not predict recurrent venous thromboembolism in cancer patients: results from the Hokusai-VTE Cancer study Floris T.M. Bosch Received Received
  PB-1038 Incidence, Risk Factors and Clinical Outcomes of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the BACAP Cohort Corinne Frere Received Received
  PB-1039 Bleeding in the Prevention of Cancer-Associated Venous Thromboembolism: Secondary Analysis of the AVERT Study Lana A. Castellucci Received Received
  PB-1040 Incidence of venous thromboembolism in patients with advanced stage cervico-uterine cancer Gabriela Cesarman-Maus Received Received
  PB-1044 Portal Vein Thrombosis as a Prognostic Factor for Survival Rate in Liver Cirrhosis with Hepatocellular Carcinoma Patients Andree Kurniawan Received Received
  PB-1045 Incidentally detected venous thromboembolism in cancer patients: Results from the Hokusai VTE Cancer trial Frits Mulder Received Received
  PB-1046 The performance of the Ottawa score in predicting recurrence in cancer patients with incidental pulmonary embolism Frits I. Mulder Received Received
  PB-1048 Role of microRNAs in venous thromboembolic disease of patients with lung cancer Julia Oto Received Received
  PB-1050 Prospective Registry of Cancer and Events Involving Venous Thromboembolism (PERCEIVE): 12-month outcomes Gloria Petralia Received Received
  PB-1052 Catheter Related Thrombosis in Patients with Hematologic Malignancies: A Venous ThromboEmbolism Network US (VENUS) Multicenter Retrospective Cohort Study Lisa Baumann Kreuziger Received Received
  PB-1053 Evaluation of Platelet Parameters in a Prospective Cohort of Healthy Subjects in Relation to Cancer Diagnosis Marina Marchetti Received Received
  PB-1055 Cancer associated thrombosis and direct oral anticoagulants: a meta-analysis of randomised clinical trials Marilyn Rees Received Received
  PB-1056 Incidental Pulmonary Embolism (IPE): Clinical Implication of Contemporaneous Cancer Response Status and Swiftness of PE Reporting Anthony Maraveyas Received Received
  PB-1057 Incidental Pulmonary Embolism (I-PE): How Important Are Abnormal Conventional Lab Indices in Predicting Clinical Outcomes? Farzana Haque Received Received
  PB-1061 Perioperative Management of Direct Oral Anticoagulants: A Single Centre Observational Study Stephanie P´ng Received Received
  PB-1062 Comparison of Outcomes in Patients Undergoing Periprocedural Interruption of Warfarin or Direct Oral Anticoagulants Brian Haymart Received Received
  PB-1063 A Retrospective Analysis of the real-world use of Idarucizumab at Two Tertiary Care Centres in Toronto, Canada Jameel Abdulrehman Received Received
  PB-1064 Reversal of warfarin using low dose Prothromplex Total, a 4-factor prothrombin complex and its implications on fix-dosing regimens Shu Hui Yeang Received Received
  PB-1065 Perioperative Management of Anticoagulant Therapies in Elderly Patients Undergoing Orthopedic Surgery: Preliminary Results from the ORTHO-START Registry Elvira Grandone Received Received
  PB-1066 Idarucizumab for dabigatran reversal, the first 6 months in a tertiary center Matt Wheeler Received Received
  PB-1067 Use of Low Molecular Weight Heparin during the Postoperative Period: Perioperative Management Plan of Patients Treated with Direct Oral Anticoagulants Desiree Campoy Received Received
  PB-1069 Oral Anticoagulant-associated Bleeding Requiring Hospitalization: Incidences, Risk Factors and Outcomes Kochawan Boonyawat Received Received
  PB-1070 Risk for Major and Fatal Bleeding After Discontinuing Oral Anticoagulation for Unprovoked Venous Thromboembolism: Systematic Review and Meta-analysis Faizan Khan Received Received
  PB-1071 Excessive Bleeding on Dabigatran Therapy Possibly Due to Genetically Predisposed Low Transport Activity of ABCB1 - A Case Report Silva Zupancic-Šalek Received Received
  PB-1072 Does INR predict bleeding events in children on warfarin? A longitudinal study Natsaruth Songthawee Received Received
  PB-1073 What is the incidence and severity of abnormal uterine bleeding associated with rivaroxaban in the treatment of VTE and is there an impact on treatment satisfaction? Early results from the ´Follow-up In Rivaroxaban patients in Setting of Thromboembolism´ Vicky Speed Received Received
  PB-1075 Analysis of Bleeding Events on Prophylactic Rivaroxaban in the CASSINI Study Gerald Soff Received Received
  PB-1076 Risk of bleeding according to renal function in patients with venous thromboembolic disease under treatment with enoxaparin Fernando Chuliber Received Received
  PB-1077 Resumption of Anticoagulant Therapy After Anticoagulant-Related Bleeding: A Population-Based Cohort Study Deborah Siegal Received Received
  PB-1080 Management and outcome of bleeding complications in patients treated with direct oral anticoagulants - updated interim analysis Roisin Bavalia Received Received
  PB-1081 Effect of polypharmacy on bleeding of rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism Ingrid Bistervels Received Received
  PB-1083 Factor Xa Inhibitor Antidote, Andexanet Alfa Differentially Reverses the Effects of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Fakiha Siddiqui Received Received
  PB-1084 Management of Oral Anticoagulant Reversal Prior to Emergency Surgery: Are we Following Guidelines in the United States? Jerrold Levy Received Received
  PB-1085 Efficacy of Idarucizumab to Reverse the Anticoagulant Effect of Dabigatran in Emergency Situations Laura Francisca Ávila Idrovo Received Received
  PB-1086 Effect of 4F-PCC Weight Capped Dosing on INR Reversal for Patients with Life-threatening Bleeding or Requiring Emergent Surgery Jessica Rimsans Received Received
  PB-1088 Coordinating Emergent Procedures after Factor Xa Inhibitor (Xai) Reversal with Andexanet Alfa Sarah Culbreth Received Received
  PB-1089 Pharmacokinetics of direct oral anticoagulants in overdose in self-poisoned patients admitted to the intensive care unit: a bi-center observational study Virginie Siguret Received Received
  PB-1090 Differential Effects of Dabigatran, Rivaroxaban, Apixaban, Edoxaban and Betrixaban on Fibrinokinetics and their Modulation by FEIBA Fakiha Siddiqui Received Received
  PB-1092 Response to New Oral Anticoagulants in Nigerian Patients with Venous Thromboembolism Wuraola A. Shokunbi Received Received
  PB-1093 The Use of Direct Oral Anticoagulants in Inherited Antithrombin Deficiency Andrew Doyle Received Received
  PB-1094 Therapy Persistence, Adherence and Predictors for Non-adherence in Patients who Switched from Vitamin K Antagonists to Direct Oral Anticoagulants Myrthe M. A. Toorop Received Received
  PB-1099 Effectof Anticoagulant Treatment on Pain in Distal Deep Vein Thrombosis: An Ancillary Analysis from the CACTUS Trial Marc Righini Received Received
  PB-1101 Automated IVC Filter Retrieval Requests and Haematology Liaison Improves Documentation and Retrieval of Temporary Inferior Vena Cava Filters: A Quality Improvement Initiative Lara N. Roberts Received Received
  PB-1102 Mesoglycan vs Placebo in Secondary Prevention of Superficial Vein Thrombosis. Rationale and Protocol Giuseppe Camporese Received Received
  PB-1103 Drug-drug Interactions of Direct Oral Anticoagulants in Clinical Settings: A Systematic Review Ming Li Received Received
  PB-1105 An Audit of the Use of the Direct Oral Anticoagulants (DOACs) in Clinical Practice: 6 Years of Data Sue Rhodes Received Received
  PB-1107 Clinical Predictors of Pulmonary Embolism for Inpatients: Are Computed Tomography Pulmonary Angiograms Being Requested Appropriately? Retrospective Analysis Lisa Luo Lan Ling Received Received
  PB-1109 Anticoagulant Treatment Satisfaction and Concerns among Patients who Switched from Vitamin K Antagonists to Direct Oral Anticoagulants Myrthe M.A. Toorop Received Received
  PB-1110 Superficial Vein Thrombosis (SVT) - treatment of SVT < 3cm from the deep vein with therapeutic DOAC - too close to call? Marilyn Rees Received Received
  PB-1111 Recurrence Risk According to Anticoagulant Prescribed for the Secondary Prevention of Venous Thrombosis Neil Zakai Received Received
  PB-1112 Efficacy and Safety of Apixaban for Treatment of Venous Thromboembolism in a Daily Practice-based Cohort Stephan V. Hendriks Received Received
  PB-1114 Venous Thromboembolism in Asia and Worldwide: Emerging Insights from GARFIELD-VTE Pantep Angchaisuksiri Received Received
  PB-1115 Low Level of Antithrombin Causes Underestimation of Anti-Xa and Discrepancy of Anti-Xa Test and Activate Partial Thromboplastin Time in the Monitoring of Heparin Ari Ahn Received Received
  PB-1116 Outcomes in the secondary prevention of cerebral venous thrombosis in cancer only population Cristhiam Rojas Hernandez Received Received
  PB-1118 Incidence and characteristics of venous thromboembolism in East Asian primary central nervous system lymphoma Sung-Soo Yoon Received Received
  PB-1120 Extended anticoagulation for unprovoked venous thromboembolism: a survey on physicians´ considerations and guideline adherence Maria Adriana de Winter Received Received
  PB-1121 MAC Project - Monitoring Anti-Coagulant therapy - Preliminary result from 2 years follow-up with Rivaroxaban users Giuseppe Camporese Received Received
  PB-1122 Anticoagulant Treatment Patterns Among Venous Thrombosis Patients With Active Cancer: a Retrospective Analysis Using Four US Claims Databases Daniel Wiederkehr Received Received
  PB-1124 Inferior vena cava filters in venous thromboembolism: indications, complications and extraction predictors Fernando Chuliber Received Received
  PB-1127 A rock and a hard place - are we balancing bleeding and thrombotic risk in patients with thrombocytopenia? Amanda Tey Received Received
  PB-1128 Retrospective study of the management of anticoagulant therapy in the pacemaker implant. Experience in an intensive care unit Pablo Romero Garcia Received Received
  PB-1129 Superficial vein thrombosis: to treat beyond 3cm? Marilyn Rees Received Received
  PB-1131 The use of apixaban or rivaroxaban in patients taking calcineurin inhibitors (CNIs): a review of therapeutic levels Beverley J Hunt Received Received
  PB-1135 Therapeutic monitoring of Rivaroxaban plasma levels in 31 patients with or without major bleeding events (MBE) in a single centre in Singapore Lester Jun Long Wong Received Received
  PB-1136 Prescribing practises of dabigatran in patients presenting with bleeding and requiring major surgery in a tertiary New Zealand Centre Matt Wheeler Received Received
  PB-1138 Incidence and characteristics of double lumen induced central venous catheter-related thromboembolism in hemodialytic patients Andree Kurniawan Received Received
  PB-1139 Evaluation of strategies focused on empowerment and change of behavior with a potential utility in patients with thromboembolic disorders Luci Dusse Received Received
  PB-1140 Therapeutic monitoring of Apixaban levels in 17 patients in a single centre in Singapore Christina Lai Lin Sum Received Received
  PB-1141 GMP Manufactured Ovine Mucosal Enoxaparin Is Comparable to Commercially Available Porcine Mucosal Enoxaparin Manoj Niverthi Received Received
  PB-1142 Ovine Mucosal Enoxaparin Exhibit Comparable Pharmacokinetic Profiles to Porcine Mucosal Enoxaparin Ahmed Kouta Received Received
  PB-1143 Vitamin K Antagonist vs Direct Oral AnticoagulantAs Anticoagulant Therapy in Patients with Inherited and Acquired Thrombophilia Pável Olivera Received Received
  PB-1147 Intracardiac blood sampling reveals a better inhibition of hemostasis activation by dabigatran as compared to vitamin K antagonists during cryoballoon catheter ablation in atrial fibrillation Zsuzsa Bagoly Received Received
  PB-1149 The Effect of Fasting Ramadan on the Efficacy and Safety of Oral Anticoagulants Fakhr Alayoubi Received Received
  PB-1151 The Mortality Outcomes and Survival Patterns of Myeloproliferative Neoplasm Registry in Malaysia Yee Yee Yap Received Received
  PB-1157 A Diabetic Microvascular Whole Blood Flow Model as a New Tool to Study Diabetes-Associated Thrombotic Complications Verena Schroeder Received Received
  PB-1158 Frequency of Arterial Thromboembolism in Patients with Cancer: A Systematic Review Allen Li Received Received
  PB-1160 Combination of high levels of fibrinogen and high sensitivity C-reactive protein enhances risk of acute coronary syndrome Chananikan Makmool Received Received
  PB-1164 Endocan and homocysteine levels in Brazilian Renal Transplant Recipients Luci Dusse Received Received
  PB-1167 Cardiovascular Diseases and Use of Antithrombotic Agents in Patients with End-stage Renal Disease on Hemodialysis: Cross-sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in HemoDIalysis Patients (VIVALDI) Oliver Königsbrügge Received Received
  PB-1171 Thrombin generation and cardiovascular events in patients with peripheral arterial disease and patients with abdominal aortic aneurysm Daniela Calderaro Received Received
  PB-1174 Experiences in Carotid Artery Dissection in Children Patcharee Komvilaisak Received Received
  PB-1175 Audit of the Use of the GEKO Device on an Acute Stroke Unit (ASU) Sue Rhodes Received Received
  PB-1177 Rheological and Hemostatic Aspects of Venous Thromboembolism in Patients with Severe Stroke Kostiantyn Stepanchenko Received Received
  PB-1179 Performance of point-of care INR as part of pre-thrombolysis laboratory panel Tuukka Helin Received Received
  PB-1185 Assessment of single-factor deficiency sensitivity of three APTT reagents Claire Martin Received Received
  PB-1187 The Calibrated Automated Thrombinography for Hemophilia Treatment Monitoring Natalya Silina Received Received
  PB-1188 Comparison of Factor VIII Half-life as Determined Using Two Web-accessible Population-based Pharmacokinetic Applications Jerome Teitel Received Received
  PB-1190 Laboratory Measurement of Emicizumab Requires a Product Specific Calibrator Helen Wilmot Received Received
  PB-1191 Thrombin-mediated Activation of Factor VIII is Insufficient to Produce All Necessary Cofactor Activity in vivo Ivan Peyron Received Received
  PB-1192 The Traceability of Commercial Plasma Calibrators to the Plasma International Standard for Factor IX Helen Wilmot Received Received
  PB-1193 Heterogeneity in levels of FVIII and VWF expression in subpopulations of human endothelial cells David Lillicrap Received Received
  PB-1195 Recombinant FVIII-neutralising antibodies: characteristics and application in product testing and ex vivo models of haemophilia A Carmen Coxon Received Received
  PB-1196 Paediatric factor VIII and IX reference intervals using STA®-ImmunoDef VIII and STA®-ImmunoDef IX Natasha Letunica Received Received
  PB-1199 PBMCs from Healthy Individuals Respond Stronger and Differently towards FVIII than towards Myelin-oligodendrocyte Glycoprotein Christoph Königs Received Received
  PB-1200 Relationship of Markers of Inflammation, Infection, and Endothelial Function to Mortality and Severity of Coagulopathy in Patients with Sepsis-associated DIC Matthew Rondina Received Received
  PB-1201 Thrombin Time Test of Patients with Liver Disease Attending Medicine Outpatient Department UCTH, Calabar, Nigeria Dorathy Chioma Okpokam Received Received
  PB-1202 Increased Platelet Contribution to Clot Strength in Cirrhotic Patients with Non-malignant Recent Portal Vein Thrombosis Ecaterina Scarlatescu Received Received
  PB-1207 Intraperitoneal Activation of the Coagulation System via Tissue Factor-exposing Extracellular Vesicles and Enhanced Fibrinolysis in Patients with Advanced Chronic Liver Disease and Ascites Johannes Thaler Received Received
  PB-1208 Evaluation of endothelial dysfunction and hypercoagulability markers in sickle cell anemia patients with and without hydroxyurea therapy Bidossessi Wilfried Hounkpe Received Received
  PB-1209 Coagulation imbalance in patients with Acute-on-Chronic Liver Failure (ACLF) measured by global and classical coagulation tests Elena Campello Received Received
  PB-1212 Increased Parameters of Thrombin Generation in Patients with Chronic Urticaria that Associate Angioedema Alvaro Fernandez-Pardo Received Received
  PB-1213 A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity Vladimir Bogdanov Received Received
  PB-1214 Efficiency of Anticoagulant Protein C System in Patients with Primary Myelofibrosis Olesia Matvienko Received Received
  PB-1221 Endothelial Protein C Receptor (EPCR) Levels and EPCR Gene A3 Haplotype in Patients with Sickle Cell Anemia Anil Tombak Received Received
  PB-1225 Clinical presentation and management of homozygous protein C deficiency:Case Study Hatice Ilgen Sasmaz Received Received
  PB-1226 New, Highly Sensitive and Specific Multiplatform Latex Automated Turbidimetric Assay for Measurement of Free Protein S in Plasma Claire Dunois Received Received
  PB-1227 Polymorphisms in Non-coding Regions of the Protein C Gene Regulate Plasmatic Protein C Levels Alvaro Fernandez-Pardo Received Received
  PB-1228 Competitive Binding, and Accounting for Procoagulant Platelets, Significantly Change Thrombin Profiles in in vitro Coagulation Mohan Anand Received Received
  PB-1229 New Functional Test for the TFPIa Cofactor Activity of Protein S Working in Synergy with FV-Short Björn Dahlbäck Received Received
  PB-1231 Determining the Contribution of FXa Activation of FV to Thrombin Generation Using TIX-5: Variation in Healthy Controls and Association of High TIX-5 Sensitivity with Complications in Patients on Vitamin K Antagonists (VKAs) Anja Maag Received Received
  PB-1235 A proximity-based in silico approach to identify redox-labile disulfide bonds: the example of FVIII Carmen Coxon Received Received
  PB-1240 Heme induces expression and activation of hematopoietic tissue factor via TLR4 and PDIA3-dependent signaling pathways Bidossessi Wilfried Hounkpe Received Received
  PB-1245 Longitudinal Evaluation of Plasma Circulating Microparticles and Serum Biomarker Levels in Women Destined to Develop Preeclampsia Shrimati Shetty Received Received
  PB-1246 Investigation of Pharmacodynamic Biomarkers and Neutralizers for ONO-7684 (ONO-5450598), an Oral FXIa Inhibitor Sho Kouyama Received Received
  PB-1247 Abstract 1: Assessment of Validated Risk Assessment Models and a Biomarker Ubiquitous in Routine Clinical Care to Identify Hospitalized Medical Patients at Risk for 90-day Post-discharge Venous Thromboembolism Scott Woller Received Received
  PB-1248 Laboratory Marker of Hypercoagulability: A Ratio Combining Thrombin-generation with Fibrin-clot-Formation Debora Bertaggia Calderara Received Received
  PB-1249 Antiphospholipid Antibodies and Thrombosis in BCR-ABL Negative Myeloproliferative Neoplasms Rolandas Gerbutaviius Received Received
  PB-1250 Soluble P-selectin Level in Diagnosis of Deep Vein Thrombosis in Adult Myanmar Population May Thandar Oo Received Received
  PB-1252 Effect of Standard and Intensive Insulin Therapy on Membrane-Bound Tissue Factor and Plasma Coagulation Biomarkers in Patients with Hyperglycemia and Acute Stroke: Differential Effects of rtPA Administration A Koneti Rao Received Received
  PB-1253 Global Coagulation Assays in Transgender Individuals Hui Yin Lim Received Received
  PB-1256 Absence of Measurable Contact System Activation of Coagulation during Hemodialysis: A Randomized Crossover Study Christelle Orlando Received Received
  PB-1257 Potential Role of High-sensitive Troponin T in Identification of Patients with Pulmonary Embolism (PE) Who May Be Treated Safely at Home? Stephan V. Hendriks Received Received
  PB-1258 Coagulation Activation in Sickle Cell Disease and the Effect of Hydroxyurea Munira Borhany Received Received
  PB-1260 Global coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significance Rowena Brook Received Received
  PB-1261 A new and rapid assay for intact fibrinogen adaptable to existing portable point-of-care devices San Pun Received Received
  PB-1262 Mutational analysis and BAT scoring assessment in patients with Glanzmann´s Thrombasthenia Kousar Perveen Received Received
  PB-1265 Abstract 2: Comparative Benefit of Adding a Biomarker Ubiquitously Available in Clinical Care to Validated Risk Assessment Models for the Identification of Hospitalized Medical Patients at Risk for 90-day Hospital-associated Venous Thromboembolism Scott Stevens Received Received
  PB-1266 Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: a cost-effectiveness analysis Marc Blondon Received Received
  PB-1267 Relationship of type 1 Plasminogen Activator Inhibitor with Glycosilated Hemoglobin levels in type 2 Diabetic Patients - Guillermo Almenara National Hospital - ESSALUD - Lima, 2016 Haydee Iparraguirre Received Received
  PB-1268 Evaluation of hemostasis in patients with Alzheimer´s disease and frontotemporal dementia by thrombin generation test Luci Dusse Received Received
  PB-1269 Thrombin generation test in Brazilian Renal Transplant Recipients Luci Dusse Received Received
  PB-1270 Patterns of JAK2-V617F Testing and Predictive Value of Erythropoietin in Adult Erythrocytosis: Experience at a Comprehensive Cancer Center Cristhiam Rojas Hernandez Received Received
  PB-1274 Plasma fibrin clot proteomics in healthy subjects: relation to clot permeability and lysis time Anetta Undas Received Received
  PB-1275 No change in coagulation factor levels after knee arthroscopy Carolina Eveline Touw Received Received
  PB-1276 Integrated GWAS and Gene Expression Data Identifies ORM1 as Potential Regulator of Plasma Cell-free DNA Levels in Families of the GAIT2 Project Jose Manuel Soria Received Received
  PB-1277 Effects of veno-venous extracorporeal membrane oxygenation on coagulation factors- a prospective observational study Deepa Jayakody Arachchillage Received Received
  PB-1278 Thrombin generation in patients with lower-leg trauma or knee arthroscopy Carolina Touw Received Received
  PB-1279 Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: a systematic review Noémie Kraaijpoel Received Received
  PB-1280 Diagnostic accuracy of four different D-dimer assays Additional analyses of the YEARS study Roisin Bavalia Received Received
  PB-1281 Evaluation of thrombin generation in patients with dermatomyositis and polymyositis Jerzy Dropinski Received Received
  PB-1283 Factors Associated with a Negative D-dimer Test in Patients Diagnosed with Acute Symptomatic Pulmonary Embolism Stefano Barco Received Received
  PB-1284 The FDP/D-dimer ratio and LDH/Hb ratio are useful to distinguish between TTP and DIC Nobushiro Nishimura Received Received
  PB-1286 Validation of a Profile of 4 Plasmatic Metabolites Associated with Venous Thromboembolism Álvaro Fernández-Pardo Received Received
  PB-1287 Specific Protein Plasma Profile Associated to Venous Thromboembolism Alvaro Fernandez-Pardo Received Received
  PB-1289 Thrombin Generation in Patients Undergoing Pharmacokinetics Analysis Nikoleta Daskoulidou Received Received
  PB-1291 Serum Lipoprotein (a) Is Not Increased in Patients with Previous Spontaneous Venous Thrombosis or Correlated with Global Fibrinolysis Andreza Lamônica Received Received
  PB-1292 TEG-based Evaluation of Gender-associated Hypercoagulability Kristen Carter Received Received
  PB-1293 Thrombin Generation and Endothelial Dysfunction in Patients with Systemic Sclerosis Jerzy Dropinski Received Received
  PB-1294 Assessment of Factor IX Padua Activity with a One-stage Clotting Method and with FXIa- and Tissue Factor/FVIIa-based Chromogenic Methods Steffen Rosén Received Received
  PB-1295 Recombinant Factor IX Fused with Albumin (rFIX-HSA) is Underassigned by One-stage Methods with Silica as Contact Activator Steffen Rosén Received Received
  PB-1296 Factor VIII, IX and XI measurement by one stage clotting assay with Silica Clotting Time Confirm reagent: A clinical laboratory helpful tool in the presence of lupus anticoagulant Marina Lopez Received Received
  PB-1297 Analytical Performance of a Modified One-Stage Clotting Assay for Measuring Emicizumab on cobas t 511/711 Analyzers Nina Richter Received Received
  PB-1304 Next Generation Sequencing as a New Tool to Improve Molecular Diagnosis of VWD Christophe Zawadzki Received Received
  PB-1307 Discrepancy between clotting versus chromogenic FVIII procoagulant assay is determined by a combination of APTT reagent and FVIII-deficient plasma Atsuo Suzuki Received Received
  PB-1312 Assays performed on samples containing emicizumab - data from a multicentre study of UK NEQAS Blood Coagulation (BC) laboratories Ian Jennings Received Received
  PB-1316 Correlation of Bleeding Scores with Flowcytometry Platelet Aggregation Test in Patients with a Suspected Bleeding Disorder Jasmina Ahluwalia Received Received
  PB-1317 Exome Sequence Findings and Bleeding Manifestations for Uncharacterized Platelet Function Disorders with Impaired Aggregation Responses and/or Non-syndromic Dense Granule Deficiency: Results from the Hamilton Platelet Disorder Study Catherine Hayward Received Received
  PB-1318 Microscopic Platelet Adhesion Assessment - An Approach towards Standardization Johanna Charlotte Clauser Received Received
  PB-1322 Standardization of Light Transmission Aggregometry for the diagnosis of inherited platelet function disorders: First inter-laboratory external quality assessment in Germany and Austria Karina Althaus Received Received
  PB-1324 Sensitive method for diagnosing a platelet population behavior after stimulation Alena Litvinenko Received Received
  PB-1327 Comparison between Plateletworks Method and Aggregation with Platelet-rich Plasma for the Evaluation of Platelet Function in Patients with Acute Coronary Syndrome Emanuel Sueldo Received Received
  PB-1328 The Total Thrombus Formation (T-TAS) Platelet Assay, a Novel Point-of-Care Test that Uses Arterial Shear Stress Evaluating Antiplatelet Therapy K.L. Zheng Received Received
  PB-1329 The Effect of Rivaroxaban on the Platelet Functional Activity Olesya Matvienko Received Received
  PB-1331 First Evidence: Reduced Thrombin-dependent Platelet Aggregation by Selected Xabans Lubica Vadelova Received Received
  PB-1333 Plasminogen Activator Inhibitor-1 Deficiency Prevents the Neonatal Chronic Lung Disease in Mice Kohei Tatsumi Received Received
  PB-1337 Inhibition of the Procarboxypeptidase U (proCPU, TAFI, proCPB2) System due to Hemolysis Joachim Mertens Received Received
  PB-1340 Fibrinolysis Patterns of Different Plasminogen Mutant Proteins in Patients with Inherited Plasminogen Deficiency: Impact on the Development of Ligneous Conjunctivitis Nadine Ajzenberg Received Received
  PB-1341 Dipicolinic Acid Release t-PA from HUVEC Hiroyuki Sumi Received Received
  PB-1342 Fibrin Clots Containing NETs Show Slower Fibrinolysis and Are Stiffer in Patients with Diabetes Judith Juliana de Vries Received Received
  PB-1343 Fibrin clot lysis analysis; tissue factor versus thrombin as activator Mai Stenulm Veirup Received Received
  PB-1344 Exploratory study of fibrinolytic parameters in patients with JAK2V617F positive essential thrombocythemia Sithakom Phusanti Received Received
  PB-1345 Fibrinogenolytic effects of Night Adder snake venoms Francisco Cyrne Pacheco Coimbra Received Received
  PB-1350 Interaction of Cationic and Anionic of Polyamidoamine Dendrimers with Plasminogen: Influence on the Structure and Activation of Zymogen by Streptokinase Liliya Mukhametova Received Received
  PB-1352 Gender-specific alteration in a2-antiplasmin incorporation in type 2 diabetes mellitus Agata Hanna Bryk Received Received
  PB-1353 Highest Nattokinase Activity in Japanese Fermented Food-Natto Hiroyuki Sumi Received Received
  PB-1354 Determinants of plasma fibrin clot lysis using three different assays in patients with aortic stenosis Jakub Siudut Received Received
  PB-1356 Elucidation of the Molecular Mechanisms of Nanobodies that Affect Plasminogen Activator Inhibitor 1 (PAI-1) Activity Highlights their Versatility in Modulating Various Stages in the PAI-1/Plasminogen Activator (PA) Interaction Paul J. Declerck Received Received
  PB-1358 Single institution experience of thrombolysis for acute pulmonary embolism in a retrospective cohort of Australian patients Ming Sheng Lim Received Received
  PB-1359 A new treatment for thrombosis prevention? Niklas Bergh Received Received
  PB-1361 Indications and Outcomes of Thrombolytic Therapy 2010-2016: A Retrospective Single Center Study Peter Verhamme Received Received
  PB-1370 Acquired FXIII inhibitor: patient characteristics and treatment outcome, a case series Sheng-Chieh Chou Received Received
  PB-1371 Venous Thromboembolism Trends and Impact in Patients with Cirrhosis: Analysis of The National Inpatient Sample Database 2003-2014 Ian Greenberg Received Received
  PB-1373 Influence of antiagregation therapy in bone marrow biopsy heamorrhagic complication Rogerio Pastore Bassitt Received Received
  PB-1374 Acquired Hemophilia A (AHA) : A Single Centre Malaysian Outlook Christopher, Chin Keong Liam Received Received
  PB-1378 Acquired von Willebrand Syndrome: A Case Series in a University Hospital in Argentina Maximiliano Villagra Iturre Received Received
  PB-1379 Acquired VKOR Inhibitor: A New Entity? Veena Selvaratnam Received Received
  PB-1380 The Paradox: Bleeding Presentation in Antiphospholipid Syndrome Veena Selvaratnam Received Received
  PB-1381 Use of a thrombin generation assay and thromboelastometry in the assessment of the efficacy of treatment with activated prothrombin complex concentrate (APCC) or recombinant Factor VIIa (rFVIIa) concentrate in patients with acquired haemophilia and in pat Krystyna Zawilska Received Received
  PB-1382 Acquired Hemophilia A Presenting in a 13 Year-old Boy - A Clinical Case Rute Preto Received Received
  PB-1383 BLEEDING COMPLICATIONS AFTER PERCUTANEOUS RENAL BIOPSY: Analysis of probable risk factors Veronica Privitera Received Received
  PB-1384 Combination of cyclophosphamide and corticosteroids therapy facilitate remission in acquired hemophilia A patients with high titers of inhibitors: A single center experience in China Naifang Ye Received Received
  PB-1386 Three successful cases of AHA patients presenting severe cardiovascular diseases treated with susoctocog-alfa (rpFVIII): a single centre experience Ezio Zanon Received Received
  PB-1388 Acquired Hemophilia A Presenting in an Elderly Man after a Thrombotic Event - A Clinical Case Rute Preto Received Received
  PB-1389 Acquired Hemophilia A and B Associated with Thyroid Cancer Successfully Treated by Activated Factor VII (rFVIIa). Case Report Alejandro Jaramillo Yepes Received Received
  PB-1390 Properdin, a positive regulator of the alternative pathway of complement, inhibits factor XI autoactivation by dextran sulphate Samantha Heal Received Received
  PB-1391 The Evaluation of Paroxismal Nocturnal Hemoglobinuria Patients who Underwent Eculizumab Therapy Fahri Sahin Received Received
  PB-1392 Reported Presentation, Treatment, Mutation Analysis and Outcome of Two Children with Atypical Hemolytic Uremic Syndrome Pongpak Pongphitcha Received Received
  PB-1395 Evaluation of fulfilment sequences of two different criteria for assessing coagulopathy in sepsis: a nationwide Japanese registry study Katsunori Mochizuki Received Received
  PB-1396 Predictive value of soluble fibrin and new diagnostic criteria by the Japanese Society on Thrombosis and Hemostasis (JSTH) for the prognosis of patients with sepsis-associated disseminated intravascular coagulation Seiji Madoiwa Received Received
  PB-1397 A Study of the Prognostic Value of Smartphone Application on Disseminated Intravascular Coagulation (DIC) Score in Prediction of 28-day Mortality Tanapun Thamgrang Received Received
  PB-1399 Use of rFIX-FP in a child with mild hemophilia B during a surgical procedure John Puetz Received Received
  PB-1400 Psychosocial Issues in Mothers of Children with Hemophilia Aya Nakao Received Received
  PB-1401 Long-term Safety of N8-GP (turoctocog alfa pegol) Prophylaxis in Patients with Severe Haemophilia A Nicola J Curry Received Received
  PB-1405 Successful Management with a Major Trauma Caused by Vehicle Accident in a Severe Hemophilia A Patient with Inhibitor under Emicizumab Treatment Sheng-Chieh Chou Received Received
  PB-1407 Menorrhagia in Congenital Factor Deficiencies Zafer Salcioglu Received Received
  PB-1409 Evaluation of the Analytical Performances of a New Emicizumab Assay on STA-R & STA Compact Max Matthieu Bourdin Received Received
  PB-1412 Validation of the Patient Reported Outcomes Burdens and Experiences (PROBE) Study Questionnaire Mark Skinner Received Received
  PB-1413 Evaluation of Active Genetic Counseling Service for Female Family Members of Hemophilia Patients in Korea Hyon Kim Received Received
  PB-1414 Identification of New Deep Intronic Variants Causing Hemophilia A by Whole F8 Gene Sequencing, mRNA Analysis and Functional Confirmation, in "Variant-Negative" French and Canadian Patients Fanny Lassalle Received Received
  PB-1415 Measuring Health Related Quality of Life (HRQoL) in Boys with Hemophilia Using Extended Half-life Clotting Factor Concentrates (CFCs) saunya dover Received Received
  PB-1417 The Outcome of Intermediate-dose Prophylaxis and On-demand Episodic Treatment for Severe Hemophilia A Patients in Taiwan - A Longitudinal Study Shyh-Shin Chiou Received Received
  PB-1422 Simoctocog-alfa (rhFVIII): an interesting option for the Immune Tolerance Induction Rescue (ITI-R) in the hemophilia A patients with high-titer inhibitors Ezio Zanon Received Received
  PB-1423 Results from the Immune Tolerance Induction (ITI) with moroctocog-alpha in a population of haemophilia A patients and high-titre inhibitors: the REF.IT Registry Ezio Zanon Received Received
  PB-1424 Comparison of Pharmacokinetic Outputs from a Non-compartmental Analysis and myPKFiT™ in Taiwanese Hemophilia Patients Shin-Nan Cheng Received Received
  PB-1425 Survey of Haemophilia Care in Nigeria: Physicians response from 35 centres in 20 states of the Federation Wuraola A. Shokunbi Received Received
  PB-1428 Clinical Use of Recombinant Factor VIII Fc (rFVIII-Fc) in Patients with Haemophilia A in a Single Centre Segolene Claeyssens Received Received
  PB-1429 The Estimated Impact of New Therapies on Factor VIII (FVIII) Use and Product Cost by 2023 Jonathan Ducore Received Received
  PB-1431 Various complications after vascular procedure in patients with hemophilia Eun Jin Choi Received Received
  PB-1433 Low-dose immune tolerance induction strategy eradicates high-titer inhibitor with poor risk(s) in hemophilia A children: a pilot study in China Zekun Li Received Received
  PB-1435 Review of a Port-A-Cath Training Programme for Caregivers in a Paediatric Haemophilia Treatment Centre Chiew Ying Lim Received Received
  PB-1436 Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa) in Spain Santiago Bonanad Received Received
  PB-1437 Management and Outcomes of Hemophilia Carriers during Pregnancy and Peripartum Period: A Hemophilia Treatment Center Experience Hana Iris Lim Received Received
  PB-1442 Transition from Standard Half-life to Extended Half-life Products in Patients with Haemophilia A and B: A Single Center Experience Marissa Johanna Maria Traets Received Received
  PB-1444 Seroprevalence and Clinical Characteristics of Viral Hepatitis in Hemophilia Patients Fahri Sahin Received Received
  PB-1451 Prediction of anti-FVIII inhibitor persistence by anti-FVIII IgG subclasses in patients with severe hemophilia a in the SIPPET cohort study Roberta Palla Received Received
  PB-1457 Results from a Prospective, Multicenter, Dose Escalating, Prophylaxis Study in Young Boys with Severe Haemophilia A in China: The China Haemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308) YUAN LI Received Received
  PB-1458 Social Participation of Patients with Haemophilia: Preliminary Results from the Nationwide ´Haemophilia in the Netherlands 6 study´ Erna van Balen Received Received
  PB-1460 Comparative Pharmacokinetic Study between Alphanate and Octanate Using WAPPS-Hemo Santiago Bonanad Received Received
  PB-1461 Clinical Assessment with Focus on Health-related Quality of Life in Adult Patients with Severe Hemophilia B Anna Buczma Received Received
  PB-1462 Acquired Haemophilia Still Remains a Complex Clinical Challenge Cristina Claudia Tărniceriu Received Received
  PB-1463 6 Consecutive Patients and 100% of Inhibitors: Is Inhibitor Development Inevitable? Cristina Catarino Received Received
  PB-1464 Utility of an Educational Material for Primary Caregivers of Pediatric Patients with Hemophilia Aida Mashenka Moreno González Received Received
  PB-1465 A Case Series of Continuous Infusion with Kovaltry® (Octocog Alfa) in Patients with Hemophilia A Jerome Teitel Received Received
  PB-1468 Comorbidity and transfusion transmitted infections in patients with severe haemophilia: Report from Taiwan Society of Thrombosis and Hemostasis registry Jiaan-Der Wang Received Received
  PB-1469 Structure, mechanical and lytic stability of fibrin and plasma coagulum generated by staphylocoagulase from Staphylococcus aureus Craig Thelwell Received Received
  PB-1472 Systemic Antifibrinolytic Agents for Hemoptysis Management in Adults with Cystic Fibrosis Jean Connors Received Received
  PB-1473 Heparin-binding Copolymer as a Universal Antidote for Low-molecular-Weight Heparins in Rats Bartłomiej Kalaska Received Received
  PB-1474 Cerebral Hemorrhage Developed in a Hemophilia A Patient without Inhibitor during Prophylactic Treatment with Emicizumab Azusa Nagao Received Received
  PB-1475 Barriers and Challenges for the Fast Treatment of Bleeds in the Non-haemophilia Treatment Centre Hospital Setting Robert Klamroth Received Received
  PB-1476 Reversal of Anticoagulation in Patients on Rivaroxaban or Apixaban (DOAC) with Major Bleeding Episodes (MBE) with 4 Factor Prothrombin Complex Concentrates (PCC): A Multicentre Retrospective Study Christian Aledia Gallardo Received Received
  PB-1478 Injectable Biotinylated Platelets for Transfusion in Clinical Trials Arnaud Dupuis Received Received
  PB-1479 Thromboelastometry in patients with positive lupus anticoagulant. Is there any potential impact on haemostasis monitoring during Cardiovascular Surgery? Marina Sol Lopez Received Received
  PB-1480 Dynamic coagulability during cardiovascular surgery and its correlations with bleeding volume Satoshi Fujii Received Received
  PB-1481 Real-world use of 4-factor prothrombin complex concentrates (4F-PCC) in warfarin-associated intracranial haemorrhage patients in Hong Kong: a descriptive patient management protocol Wing Chi Fong Received Received
  PB-1482 Management of Antithrombotic Therapy After Gastrointestinal Bleeding: A Qualitative Study of Healthcare Providers Deborah Siegal Received Received
  PB-1483 Perioperative Management of Antiplatelets and Anticoagulants in Elective Surgery James Sindone Received Received
  PB-1485 Seek and Ye Shall Find - Elearning as a Method to Improve Knowledge of Bleeding Management Louise English Received Received
  PB-1487 Efficacy of Three Factor Prothrombin Complex in Achieving Haemostasis in Patients with Major Bleeding on Anti-Coagulation - Retrospective Single Centre Study Usha Chandra Sekaran Received Received
  PB-1488 GPVI shedding contributes to platelet dysfunction in trauma-induced coagulopathy Samantha Montague Received Received
  PB-1489 Efficacy and safety of a 4-factor prothrombin complex concentrate for management of direct Xa inhibitor-induced major bleeding Paul Dobesh Received Received
  PB-1491 A Comparison of Management Strategies for Patients with Warfarin-induced Bleeding Paul Dobesh Received Received
  PB-1492 Warfarin Reversal with a 4-factor Prothrombin Complex Concentrate Prior to Urgent surgery Paul Dobesh Received Received
  PB-1493 Direct Xa-inhibitor Reversal with a 4-factor Prothrombin Complex Concentrate Prior to Urgent Surgery Paul Dobesh Received Received
  PB-1494 Comparative Studies on the Anticoagulant Activities of Orally Active Anti-Xa and Anti-IIa Agents in Whole Blood and Retrieved Plasma and their Neutralization by FEIBA Rithik Raina Received Received
  PB-1495 Idarucizumab for Dabigatran Reversal in Clinical Practice: A French Retrospective Study of 41 Cases Nicolas Gendron Received Received
  PB-1496 von Willebrand Factor in Experimental Malaria-associated Acute Respiratory Distress Syndrome Sirima Kraisin Received Received
  PB-1497 Involvement of Glycoprotein VI in Platelet Mediated Amyloid-ß Fibril Formation Lili Donner Received Received
  PB-1498 Regulation of NET formation by von Willebrand factor Kimberly Martinod Received Received
  PB-1503 Partially Methylated Domains of Fetal and Adult Liver Sinusoidal Endothelial Cells Revealed Cell-type as Well as Differentiation-stage Specificity Muhammad Ahmer Jamil Received Received
  PB-1506 Decreased Thrombin Generation Potential is Associated with Increased Thrombin Generation Markers in Sepsis Associated Coagulopathy Fakiha Siddiqui Received Received
  PB-1507 Plasma Activated Protein C Activity in the Presence of Recombinant Thrombomodulin in vivo and in vitro Takashi Ito Received Received
  PB-1508 Platelet aggregation in patients with septic shock Mathies Appel Laursen Received Received
  PB-1509 Investigating the role of tissue factor in abdominal sepsis Agostina Carestia Received Received
  PB-1511 HIGH PLASMATIC LEVELS OF CELL FREE DNA ARE ASSOCIATED WITH POOR PROGNOSIS IN SEPTIC PATIENTS Mauro Hernán Moiana Received Received
  PB-1513 Activation-specific small binding proteins targeted towards the integrin Mac-1 - Measuring inflammation by means of monocyte activation in STEMI- and ECMO-patients Patrick Malcolm Siegel Received Received
  PB-1514 Platelets and coagulation mediate bacterial adhesion to damaged and inflamed heart valves in Staphylococcus aureus endocarditis Severien Meyers Received Received
  PB-1515 Coagulation and fibrinolysis waveform analysis may identify the patients susceptible for multiple organ failure and thrombocytopenia in septic DIC Noritaka Yada Received Received
  PB-1516 Pro-inflammatory Macrophage Polarization enhances Neutrophil Extracellular Trap Degradation Patrick Haider Received Received
  PB-1517 Investigating the role of neutrophils and NETs in Staphylococcus aureus endocarditis Severien Meyers Received Received
  PB-1518 Remote Ischemic Preconditioning Does Not Influence Lectin Pathway Protein Levels in Cancer Patients Undergoing Surgery: A Randomized Controlled Trial Kristine Frederiksen Received Received
  PB-1521 MiR-146a participates in thrombo-inflammation regulating neutrophil extracellular trap formation Ana Belen Arroyo Rodriguez Received Received
  PB-1523 Developing a Novel Stem Cell and Gene Therapy System Based on Resveratrol-induced HSP70 Promoter-regulated VEGFA Expression Kowit-Yu Chong Received Received
  PB-1524 Prolonged Therapeutic Effects of Adipose-derived Stem Cells via the Photoactivation after Ischemic Injury Jianbo Wu Received Received
  PB-1526 Symptomatic Profiles of Chinese Patients with Essential Thrombocythemia Assessed by MPN 10 Score Ting Sun Received Received
  PB-1527 miR-125a-5p Regulates Human and Mouse Thrombopoiesis through Leukocyte Cytosolic Protein 1 (LCP1) Paul F. Bray Received Received
  PB-1529 Buffy coat, a potential source of hematopoietic stem cells for in vitro platelet production Irene Marini Received Received
  PB-1530 Aerobic Glycolysis and the Consequent Flux through Pentose Phosphate Pathway Fuel Platelet Activation: Small-molecule Modulators of Platelet Metabolism as Anti-thrombotic Agents Paresh Kulkarni Received Received
  PB-1531 The Highly Efficacious Antithrombotics Act as Selective Inhibitors of aIIbß3 Outside-in Signaling with a High Safety Profile Tur-Fu Huang Received Received
  PB-1532 A Proposed "ABN Score" for Prediction of Aspirin Resistance in Thai Patients with Polycythemia Vera and Essential Thrombocythemia Yingyong Chinthammitr Received Received
  PB-1533 Do paracetamol and nonsteroidal anti-inflammatory drugs affect the quality of platelets for transfusion? Dianne E. Van Der Wal Received Received
  PB-1534 APAC, a dual antiplatelet and anticoagulant - towards a local, vascular targeting antithrombotic Riitta Lassila Received Received
  PB-1535 Outside-in Integrin Signaling Induces Disabled-2 (Dab2) Ser24 Phosphorylation Causing Dab2 Dissociation from Phosphatidic Acid in Human Platelets Hui-Ju Tsai Received Received
  PB-1536 Plasma Inhibitors of Platelet Sheddase Activity - Rocks to the Scissors on the Paper Christine Lee Received Received
  PB-1538 All-trans retinoic acid (ATRA) impairs platelet function and thrombus formation and inhibits protein kinase C ßI and d phosphorylation Jianlin Qiao Received Received
  PB-1539 The mammalian target of rapamycin controls platelet integrin activation, aggregation, and ischemic stroke Robert Campbell Received Received
  PB-1540 Lenalidomide and dexamethasone enhanced platelet activation and in vitro thrombus formation under arterial flow Fehaid Alanazi Received Received
  PB-1542 The role of the formin proteins mDia1 and Fhod1 on megakaryocyte and platelet function Steve Thomas Received Received
  PB-1543 Platelet function testing by flow cytometry in venous and arterial blood: A comparative study Sofia Ramstrom Received Received
  PB-1546 Moderate decreased platelet counts but high platelet activation defects alter hemostasis and arterial thrombosis after partial hepatectomy in mice Lili Donner Received Received
  PB-1549 The rate of platelet activation varies within the normal population and does not correlate with maximal levels of platelet activation Joanne Mitchell Received Received
  PB-1550 Assessment of Platelet Function after Shear Stress Simulation Using ex vivo Closed-loop ECC Model (Modified Chandler-loop) Jan Zlamal Received Received
  PB-1552 The integrin aIIbß3 signalling pathway is hyperactivated in platelets from obese patients: a phosphoproteomic study Maria N. Barrachina Received Received
  PB-1554 Comparison of Anucleated and Nucleated Platelet Transcriptomes Andrew D. Johnson Received Received
  PB-1555 Gradient dependent inhibition of platelet stimulatory G-Protein coupled receptors is mediated through cAMP dependent pathway Ankit S Macwan Received Received
  PB-1556 Potential for ice recrystallisation inhibitors to improve cryopreserved platelet recovery and quality Lauren Waters Received Received
  PB-1557 The role of NMDA receptors in platelet specific hemostasis Lili Donner Received Received
  PB-1558 Elevated Soluble GPVI Levels in Patients with Symptomatic Aortic Stenosis and Left Ventricular Remodelling Cecile Oury Received Received
  PB-1559 Panax Notoginseng Flower Extratives and Its Saponins Attenuate Human Platelet Hyperactivity via P2Y12 Signaling Pathways in vitro Yan Yang Received Received
  PB-1560 Reelin Modulates Glycoprotein VI and Integrin Outside-in Signaling of Platelets Meike Klier Received Received
  PB-1561 Src-family kinase inhibition by dasatinib blocks both initial and subsequent platelet deposition on collagen under flow, but lacks any effect when thrombin is generated Scott Diamond Received Received
  PB-1563 Platelets express a truncated form of TrkB involved in BDNF signaling Imane Boukhatem Received Received
  PB-1566 Phosphate-induced ORAI1 expression and store operated Ca2+ entry in megakaryocytes Tamam Bakchoul Received Received
  PB-1569 Study of Calcium Signaling Dynamics in Single Platelets Daria Spiryova Received Received
  PB-1572 Combining a novel GPVI inhibitor ACT017 with conventional antiplatelet therapy provides greater inhibition of platelet-leukocyte aggregate formation Mark Thomas Received Received
  PB-1573 Ceruloplasmin reduces the ability of thrombin to cause platelet aggregation Daria Grigorieva Received Received
  PB-1574 Effect of monomeric myeloperoxidase on platelet function Irina Gorudko Received Received
  PB-1577 Multiplex profiling of Platelet Rich Plasma vs Platelet Concentrate bioproducts: A comparative analysis Laura Gutierrez Received Received
  PB-1579 "TWO-FACED TTP" - The Many Causes of Thrombotic Microangiopathy in Cancer Patients Rebecca Barrett Received Received
  PB-1581 Adult Onset Hereditary Thrombotic Thrombocytopenic Purpura (TTP) with a Novel ADAMTS13 Mutation Julian Matias Freue Received Received
  PB-1584 Clinical Safety Of Therapeutic Plasma Exchange with Fresh Frozen Plasma Inactivated with Mirasol PRT System in Patients with Acquired TTP Magdalena Letowska Received Received
  PB-1590 Evaluation of A Rapid, Fully-automated ADAMTS13 Activity Assay Josep Serra Received Received
  PB-1594 The presence of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura patients does not hamper correct determination of ADAMTS13 antigen levels Charlotte Dekimpe Received Received
  PB-1595 A NOVEL MUTATION DESCRIPTION IN LATE-ONSET PHENOTYPE CASE OF CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) Juvenal Paiva Received Received
  PB-1596 ADAMTS13 antigen together to collagen binding to von Willebrand factor (VWF:CB) and VWF antigen (VWF:Ag) were potential markers of acute disease severity in acquired thrombotic thrombocytopenic purpura (aTTP) Juvenal Paiva Received Received
  PB-1597 Severe hemolytic jaundice with thrombocytopenia at birth in congenital TTP is caused by physiological constriction of ductus arteriosus Kazuya Sakai Received Received
  PB-1598 Non-severe Congenital Deficiency of ADAMTS13 Presenting as Thrombotic Microangiopathy during Pregnancy Miguel Escobar Received Received
  PB-1599 Complement Abnormalities in a Cohort of Argentinean Patients with Atypical Hemolytic Uremic Syndrome Célia Dos Santos Received Received
  PB-1604 The Incidence of Low ADAMTS13 Activity in Systemic Lupus Erythematosus Patients with Thrombocytopenia Theera Ruchutrakool Received Received
  PB-1605 Rituximab prophylaxis in acquired Thrombotic Thrombocytopenic Purpura improves thrombus formation by shear flow-based assay Marie Scully Received Received
  PB-1606 A Survey on the use of rituximab in Korean patients with acquired thrombotic thrombocytopenic purpura Sung-Hyun Kim Received Received
  PB-1608 Red blood cells transfusion can improve hemostatic dysfunction of Heyde Syndrome Ayaka Kakiwaki Received Received
  PB-1609 Acquired thrombotic thrombocytopenic purpura occurring in advanced age: impact of a delayed onset on disease expression Andrea Artoni Received Received
  PB-1610 Long-term Neuropsychological Sequelae, Emotional Wellbeing and Quality of Life in Patients with Acquired Thrombotic Thrombocytopenic Purpura Ilaria Mancini Received Received
  PB-1611 ADAMTS-13 Inhibitor Testing Is often Negative on Initial Testing Gloria Lim Received Received
  PB-1614 Potency Adjusted Bovine Heparin is Comparable to Porcine Heparin in Patients Undergoing Open Heart Surgery Ahmed Kouta Received Received
  PB-1616 Enoxaparins Derived from Ovine (Sheep) Tissues Are Biosimilar to Branded Enoxaparin of Porcine (Pig) Origin Tishya Indran Received Received
  PB-1617 Heparins Derived from Ovine (Sheep) Mucosa Are Interchangeable to their Porcine (Pig) Counterparts Tishya Indran Received Received
  PB-1618 Bovine and Porcine Mucosal Heparins Exhibit Comparable Pharmacodynamic Behaviors at USP Potency Adjusted Doses Ahmed Kouta Received Received
  PB-1619 Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study Suqiao Yang Received Received
  PB-1620 The Independent Effect of Being a Strict Stockings Complier on the Outcome of the SOX Trial Susan Kahn Received Received
  PB-1621 External Validation of the SOX-PTS Score (Clinical Prediction Model for the Post-thrombotic Syndrome) in a Prospective Multicenter Study of Patients with Proximal Deep Vein Thrombosis Susan R Kahn Received Received
  PB-1622 Quality of Initial Anticoagulant Treatment is Not a Risk Factor for Developing Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism Gudula J.A.M. Boon Received Received
  PB-1623 Contrast Enhanced Computed Tomography Has a High Sensitivity for Diagnosing Chronic Thromboembolic Pulmonary Hypertension Eli Westerlund Received Received
  PB-1626 Can a 9-item modified villalta score adequately predict post thrombotic syndrome? A subgroup analysis from the ´Follow-up In Rivaroxaban patients in Setting of Thromboembolism´ (FIRST) Registry Vicky Speed Received Received
  PB-1627 Initial thrombus above or below popliteal fossa is more predictive than residual thrombosis for postthrombotic syndrome after episode of deep venous thrombosis - RIETE experience with 1183 patients Marijan Bosevski Received Received
  PB-1628 Sex-specific Differences in the Clinical Presentation, Surgical Complications, and Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Insights from the European CTEPH Registry Stefano Barco Received Received
  PB-1630 Substantial Increase in Quality Adjusted Life Years by Earlier Diagnosis of Chronic Thromboembolic Pulmonary Hypertension Gudula J.A.M. Boon Received Received
  PB-1631 Robotic assisted thrombotripsy allows high accurate venous recanalization in a porcine model of femoral venous thrombosis Lina Khider Received Received
  PB-1634 Virchow´s Triad: Is it Applicable to Thrombosis of Mesenteric Vessels? Bushra Moiz Received Received
  PB-1635 Utility of the DASH score after unprovoked venous thromboembolism: single centre study and long-term patient outcomes Will Thomas Received Received
  PB-1637 An Exploration of the Psychological Impact of Pulmonary Embolism Anna Tran Received Received
  PB-1638 Diagnostic Performance of Current Imaging Modalities for Diagnosing Cerebral Vein Thrombosis Lisette F. van Dam Received Received
  PB-1639 Decline in Periprocedural Anticoagulant Use in Warfarin-treated VTE Patients Following the BRIDGE Trial Publication Geoffrey Barnes Received Received
  PB-1640 Cost Savings Associated with Extended INR Testing Intervals Scott Kaatz Received Received
  PB-1641 MAC Project - Monitoring Anticoagulant Therapy Observational Study - Rationale and Protocol Giuseppe Camporese Received Received
  PB-1642 Absence of Interaction between Rivaroxaban, Tacrolimus and Everolimus in Renal Transplant Recipients Anticoagulated for Proximal Deep Vein Thrombosis or Atrial Fibrillation Giuseppe Camporese Received Received
  PB-1643 Time in Therapeutic Range (TTR) of Ghanaian VTE Patients on Warfarin Edeghonghon Olayemi Received Received
  PB-1646 MRDTI Can Distinguish Between Old and New Thrombosis in the Abdominal Aorta: A Case Report Lisette F. van Dam Received Received
  PB-1647 Rationale for Clinicians to Hospitalize Patients with Acute Pulmonary Embolism: A Post-hoc Analysis of the Hestia and Vesta Studies Stephan V. Hendriks Received Received
  PB-1648 Thrombogenic Potential in Patients Undergoing Hemodialysis Using Central Venous Catheter Luci Dusse Received Received
  PB-1649 Single Centre Retrospective Review of Non-catheter Associated upper Extremity Deep Venous Thrombosis Stephanie P´ng Received Received
  PB-1650 Birth of a coagulation clinic and its burden at the department of clinical hematology, Yangon General Hospital, Myanmar Sein Win Received Received
  PB-1652 The role of anxiety and depression in the pathogenesis of thromboembolic events currently classified as unprovoked Silvia Hoirisch-Clapauch Received Received
  PB-1653 Analysis of Central Venous Catheter Preservation on Prophylactic Rivaroxaban in the CASSINI Study Gerald A. Soff Received Received
  PB-1654 Incidences of thrombosis, major bleeding and 30-day mortality in patients receiving veno-venous extracorporeal membrane oxygenation and value of laboratory parameters at presentation in predicting outcomes Deepa Jayakody Arachchillage Received Received
  PB-1656 Treatment of PICC-related upper limb deep-vein or superficial vein thrombosis with Edoxaban. Rationale and protocol Cristiano Bortoluzzi Received Received
  PB-1657 Identifying patient values and expectations for pulmonary embolism CT scanning in the emergency department Vidushi Swarup Received Received
  PB-1658 Complication Rates after Upper Extremity Venous Thrombosis: a Systematic Review and Meta-analysis Rick Ikesaka Received Received
  PB-1659 Thrombin Generation during Bleeding in Orally Anticoagulated Patients: Reversal Can Lead to Hypercoagulability Aurélien Lebreton Received Received
  PB-1660 Cerebral Venous Thrombosis Risk Factors Milan Kostal Received Received
  PB-1662 Recurrences after Splanchnic Vein Thrombosis: Risk Factors and Efficacy of Vitamin K-Antagonists in a Retrospective Monocenter Cohort of 207 Patients Valerio De Stefano Received Received
  PB-1663 Extended INR Recall Interval in Patients with Stable INR - Real World Experience Petr Kessler Received Received
  PB-1664 An easy-to-use tool to flag patients at risk of poor INR control: a streak of subtherapeutic INRs Jasper H.A. van Miert Received Received
  PB-1665 Risk factors of Recurrences after Stopping Anticoagulant of First Non-Cancer Related Venous Thromboembolism in Thai Patients: A Prospective Cohort Study Pitiphong Kijrattanakul Received Received
  PB-1668 Non hepatic causes of Adult Splanchnic Vein Thrombosis. A monocentric report of 24 cases Zoubida Tazi Mezalek Received Received
  PB-1669 Interim analysis - Safety and efficacy of rivaroxaban in a patient population with short bowel syndrome; a prospective observational cohort study Roisin Bavalia Received Received
  PB-1670 Incidence of venous thromboembolism in post-bariatric surgery patients Feras Almarshad Received Received
  PB-1671 Influence of polymorphisms in the CYP2C9, VKORC1, MDR1 and APOE genes and other patient variables on warfarin dose in patients treated at anticoagulation clinics in Brazil Luci Dusse Received Received
  PB-1672 Diagnostic accuracy of limited versus whole-leg ultrasonography for suspected deep vein thrombosis: a systematic review and meta-analysis Noémie Kraaijpoel Received Received
  PB-1673 Brazilian version of the oral anticoagulation knowledge test: an item response theory approach Luci Dusse Received Received
  PB-1675 Management of anticoagulant therapy around delivery: results from the ongoing Highlow study Ingrid Bistervels Received Received
  PB-1676 A quality improvement program to reduce the use of inferior vena cava filters for unnecessary indications in a tertiary care center Tzu-Fei Wang Received Received
  PB-1677 Safety and Efficacy of Full Dose Dabigatran in the Treatment of Deep Vein Thrombosis in a Very Young Adolescent Franco Piovella Received Received
  PB-1678 Direct Oral Anticoagulant Laboratory Assay Assessment at a Large Academic Medical Center Sharonlin Bhardwaj Received Received
  PB-1679 The CTPA Epidemic? Sarah Kelliher Received Received
  PB-1680 Innovation in Interprofessional Education and Curriculum Development: A Simulation-based Anticoagulation Management Workshop for Hematology Trainees Prakash Vishnu Received Received
  PB-1682 ISTH Guidelines and Apixaban Plasma Levels in Obese Patients Marilyn Rees Received Received
  PB-1687 Antithrombin and D-dimer in Predicting Pregnancy Complications in the 3rd Trimester of Pregnancy Ning Tang Received Received
  PB-1690 Assessment of the Knowledge about Venous Thromboembolism (VTE) on Pregnant Women Attending Kigali Referral Hospitals Eva Hortas Received Received
  PB-1692 Effects of Low-dose Combined Oral Contraceptives and Protein S K196E Mutation on Anticoagulation Factors: A Prospective Observational Study Toshiyuki Miyata Received Received
  PB-1693 Activated Partial Thromboplastin Time-based Unfractionated Heparin Dosing Protocol for Pregnant Patients Reiko Neki Received Received
  PB-1695 Current ISTH Registries on Women´s Health Issues in Thrombosis and Haemostasis: Powerful Tools for Improved Data Collection and Outcome Measurement Maha Othman Received Received
  PB-1697 High titer of false positive venereal disease research laboratory (f+VDRL) test among patients with Obstetric Antiphospholipid Antibodies Syndrome (OAPS) having triple positivity profile of antiphospholipid antibodies (aPL) Silvia Perés Received Received
  PB-1699 Study of utilisation of combined hormonal contraceptives in Europe Deeksha Khialani Received Received
  PB-1703 Transfusions during Pregnancy or Postpartum in 3 Italian Tertiary Level Obstetrics Departments: A Retrospective Analysis Elvira Grandone Received Received
  PB-1704 Pulmonary Embolism in women transfused after postpartum hemorrhage: a single Centre audit Elvira Grandone Received Received
  PB-1705 The Thromboelastography G Parameter as a Potential Marker for Coagulation Status Evaluation in Elderly Puerperant Qiuya Lu Received Received
  PB-1706 Is Platelets Count Useful for Preeclampsia Diagnosis? Luci Dusse Received Received
  PB-1708 Systemic Soluble Mediators in HELLP Syndrome Case Report Luci Dusse Received Received
  PB-1709 The Challenges of Managing Severe Haemophilia A and Pregnancy in Same Sex Couples Bella Madan Received Received
  PB-1710 Pregnancy, Childbirth and Neonatal Outcomes in Women with Inherited Bleeding Disorders Lisa Clarke Received Received
  PB-1712 A model for the dual actions of plasminogen activator inhibitor type-2 (PAI-2) during oxidative stress Jordan Cater Received Received
  PB-1714 Is the Resolution of Inflammation Altered in Preeclampsia? Luci Dusse Received Received
  PB-1715 An obstetric thrombophilia patient with heterozygous factor V Leiden (A1691G) and homozygous C677T MTHFR mutations in family history; case report and literature review Justyna Teliga-Czajkowska Received Received
  PB-1716 Outcome of Pregnancies Inadvertently Conceived during Rivaroxaban Anticoagulation Therapy - Case Series Justyna Teliga-Czajkowska Received Received
  PB-1718 The impact of glycemic control in pregnant women with gestational and pregestational diabetes on coagulation status and lipid metabolism Justyna Teliga-Czajkowska Received Received
  PB-1719 Inherited Thrombophilia in Infertility Patients in Macedonia Elena Petkovikj Received Received
  PB-1722 Platelet indices and cardiovascular events: prospective findings from the CAMELIA study Gian Marco Podda Received Received
  PB-1724 Gene Therapy Knowledge and Perceptions: Results of an International ISTH Survey K. John Pasi Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
09:21
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ISTH 2019 Congress

 

July 6-10, 2019 Melbourne
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 06/07/2019 TO 06/07/2019
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.ISTH2019.2019 




PosterSessionOnline
Logo Draft
 
Logo Cert